Document:

EX-10.5

 Exhibit 10.5 
  

 
  

 
 ASSET REPRESENTATIONS REVIEW AGREEMENT

 SANTANDER DRIVE AUTO RECEIVABLES TRUST 2021-2, 

as Issuer 
 and 

SANTANDER CONSUMER USA INC., 
 as
Sponsor and Servicer 
 and 

CLAYTON FIXED INCOME SERVICES LLC, 

as Asset Representations Reviewer 
  

 
 Dated as of
May 26, 2021 
  
  

 
  

 
  
  

 TABLE OF CONTENTS 

Page 
  

							
	 ARTICLE I.
          DEFINITIONS
	  	 	1	 
			
	 Section 1.01
	 	 Definitions
	  	 	1	 
	 ARTICLE II.          ENGAGEMENT;
ACCEPTANCE
	  	 	3	 
			
	 Section 2.01
	 	 Engagement; Acceptance
	  	 	3	 
			
	 Section 2.02
	 	 Eligibility of Asset Representations Reviewer
	  	 	3	 
			
	 Section 2.03
	 	 Independence of the Asset Representations Reviewer
	  	 	3	 
		
	 ARTICLE III.         DUTIES OF THE ASSET
REPRESENTATIONS REVIEWER
	  	 	3	 
			
	 Section 3.01
	 	 Review Scope
	  	 	3	 
			
	 Section 3.02
	 	 Review Notices
	  	 	4	 
			
	 Section 3.03
	 	 Review Materials
	  	 	4	 
			
	 Section 3.04
	 	 Missing or Incomplete Review Materials
	  	 	4	 
			
	 Section 3.05
	 	 The Asset Review
	  	 	5	 
			
	 Section 3.06
	 	 Review Period
	  	 	5	 
			
	 Section 3.07
	 	 Review Report
	  	 	5	 
			
	 Section 3.08
	 	 Completion of Review for Certain Subject Receivables
	  	 	6	 
			
	 Section 3.09
	 	 Termination of Review
	  	 	6	 
			
	 Section 3.10
	 	 Review and Procedure Limitations
	  	 	6	 
			
	 Section 3.11
	 	 Review Systems
	  	 	6	 
			
	 Section 3.12
	 	 Representatives
	  	 	7	 
			
	 Section 3.13
	 	 Dispute Resolution
	  	 	7	 
			
	 Section 3.14
	 	 Records Retention
	  	 	7	 
			
	 Section 3.15
	 	 No Delegation
	  	 	7	 
		
	 ARTICLE IV.         PAYMENTS TO ASSET
REPRESENTATIONS REVIEW
	  	 	8	 
			
	 Section 4.01
	 	 Annual Fee
	  	 	8	 
			
	 Section 4.02
	 	 Review Fee
	  	 	8	 
			
	 Section 4.03
	 	 Dispute Resolution Expenses
	  	 	8	 
			
	 Section 4.04
	 	 Payment
	  	 	9	 
			
	 Section 4.05
	 	 Payments by the Issuer
	  	 	9	 

  

					
		  	-i-	  	 Asset Representations Review Agreement

(SDART 2021-2)

 TABLE OF CONTENTS 

(continued) 
 Page 

 

							
		
	 ARTICLE V.           OTHER MATTERS
PERTAINING TO THE ASSET REPRESENTATIONS REVIEWER
	  	 	9	 
			
	 Section 5.01
	 	 Representations and Warranties of the Asset Representations Reviewer
	  	 	9	 
			
	 Section 5.02
	 	 Limitation of Liability of Asset Representations Reviewer
	  	 	10	 
			
	 Section 5.03
	 	 Indemnification of Asset Representations Reviewer
	  	 	10	 
			
	 Section 5.04
	 	 Indemnification by Asset Representations Reviewer
	  	 	11	 
		
	 ARTICLE VI.         REMOVAL, RESIGNATION;
SUCCESSOR ASSET REPRESENTATION REVIEWER
	  	 	11	 
			
	 Section 6.01
	 	 Eligibility Requirements for Asset Representations Reviewer
	  	 	11	 
			
	 Section 6.02
	 	 Resignation and Removal of Asset Representations Reviewer
	  	 	12	 
			
	 Section 6.03
	 	 Successor Asset Representations Reviewer
	  	 	12	 
			
	 Section 6.04
	 	 Merger, Consolidation or Succession
	  	 	13	 
		
	 ARTICLE VII.       TREATMENT OF CONFIDENTIAL
INFORMATION
	  	 	13	 
			
	 Section 7.01
	 	 Confidential Information
	  	 	13	 
			
	 Section 7.02
	 	 Safeguarding Personally Identifiable Information
	  	 	15	 
		
	 ARTICLE VIII.      OTHER MATTERS PERTAINING TO THE
ISSUER
	  	 	16	 
			
	 Section 8.01
	 	 Termination of this Agreement
	  	 	16	 
			
	 Section 8.02
	 	 Limitation of Liability
	  	 	16	 
		
	 ARTICLE IX. MISCELLANEOUS PROVISIONS
	  	 	17	 
			
	 Section 9.01
	 	 Amendment
	  	 	17	 
			
	 Section 9.02
	 	 Notices, Etc
	  	 	18	 
			
	 Section 9.03
	 	 Severability Clause
	  	 	18	 
			
	 Section 9.04
	 	 Governing Law
	  	 	18	 
			
	 Section 9.05
	 	 Headings
	  	 	19	 
			
	 Section 9.06
	 	 Counterparts and Electronic Signature
	  	 	19	 
			
	 Section 9.07
	 	 Waivers
	  	 	19	 
			
	 Section 9.08
	 	 Entire Agreement
	  	 	19	 
			
	 Section 9.09
	 	 Severability of Provisions
	  	 	19	 
			
	 Section 9.10
	 	 Binding Effect
	  	 	20	 
			
	 Section 9.11
	 	 Cumulative Remedies
	  	 	20	 

  

					
		  	-ii-	  	 Asset Representations Review Agreement

(SDART 2021-2)

 TABLE OF CONTENTS 

(continued) 
 Page 

 

							
			
	 Section 9.12
	 	 Nonpetition Covenant
	  	 	20	 
			
	 Section 9.13
	 	 Submission to Jurisdiction; Waiver of Jury Trial
	  	 	20	 
			
	 Section 9.14
	 	 Third-Party Beneficiaries
	  	 	21	 

 Exhibit A – Agreed Upon Procedures 

  

					
		  	-iii-	  	 Asset Representations Review Agreement

(SDART 2021-2)

 ASSET REPRESENTATIONS REVIEW AGREEMENT 

This ASSET REPRESENTATIONS REVIEW AGREEMENT is made and entered into as of May 26, 2021 (this “Agreement”), by and
between Santander Drive Auto Receivables Trust 2021-2, a Delaware statutory trust (the “Issuer”), Santander Consumer USA Inc., an Illinois corporation (“SC”, and in its
capacity as sponsor, the “Sponsor”, and in its capacity as servicer, the “Servicer”), and Clayton Fixed Income Services LLC, a Delaware limited liability company (“Clayton”, and in its capacity as
asset representations reviewer, the “Asset Representations Reviewer”). 
 WHEREAS, the Issuer will engage the Asset
Representations Reviewer to perform reviews of Receivables for compliance with the representations and warranties made by the Sponsor regarding such Receivables. 

NOW, THEREFORE, in consideration of the mutual agreements herein contained and other good and valuable consideration, the receipt and
sufficiency of which are hereby acknowledged, the parties hereto, intending to be legally bound hereby, agree as follows: 
 ARTICLE I.

 DEFINITIONS 

Section 1.01 Definitions. Except as otherwise defined herein or as the context may otherwise require, capitalized terms used but
not otherwise defined herein are defined in Appendix A to the Sale and Servicing Agreement dated as of the date hereof (as from time to time amended, supplemented or otherwise modified and in effect, the “Sale and
Servicing Agreement”) between the Issuer, the Servicer, Santander Drive Auto Receivables LLC and Citibank, N.A., as indenture trustee, which also contains rules as to usage that are applicable herein. 

Whenever used in this Agreement, the following words and phrases shall have the following meanings: 

“Annual ARR Fee” has the meaning set forth in Section 4.01. 

“Asset Review” means the completion by the Asset Representations Reviewer of the “Tests” set forth in Exhibit A for
each Subject Receivable as further described in Section 3.05. 
 “Client Records” has the meaning
set forth in Section 3.14. 
 “Confidential Information” has the meaning set forth in
Section 7.01. 
 “Disclosing Party” has the meaning set forth in
Section 7.01. 
 “Eligible Asset Representations Reviewer” means a Person who (i) is not,
and is not Affiliated with, the Sponsor, the Depositor, the Servicer, the Indenture Trustee, the Owner Trustee or any of their Affiliates and (ii) was not engaged or Affiliated with a Person that was engaged by the Sponsor or any Underwriter to
perform any due diligence on the Receivables prior to the Closing Date. 

  

					
		  	1	  	 Asset Representations Review Agreement

(SDART 2021-2)

 “Eligibility Representations” shall mean those representations identified
in Exhibit A. 
 “Indemnified Person” has the meaning set forth in Section 5.03. 

“Personally Identifiable Information” or “PII” has the meaning set forth in
Section 7.02. 
 “Privacy Laws” has the meaning set forth in
Section 7.02. 
 “Receiving Party” has the meaning set forth in
Section 7.01. 
 “Representatives” has the meaning set forth in
Section 7.01. 
 “Review Fee” has the meaning set forth in
Section 4.02. 
 “Review Invoice” means, with respect to any Asset Review, a detailed invoice
prepared by the Asset Representations Reviewer setting forth the calculation of the applicable Review Fee for such Asset Review. 

“Review Materials” means the documents, data, and other information required for each “Test” in Exhibit A. 

“Review Period” has the meaning set forth in Section 3.06. 

“Review Report” has the meaning set forth in Section 3.07. 

“Subject Receivables” means, for any Asset Review, all Receivables which are 60-Day
Delinquent Receivables as of the related Review Satisfaction Date; provided, that any Receivable repurchased by the Sponsor or the Servicer in accordance with the Transaction Documents or paid in full by the related obligor after the Review
Satisfaction Date will no longer be a Subject Receivable. 
 “Tests” mean the procedures listed in Exhibit A as applied to
the process described in Section 3.05. 
 “Test Complete” has the meeting set forth in
Section 3.08. 
 “Test Fail” has the meaning set forth in Section 3.05.

 “Test Incomplete” has the meaning set forth in Section 3.05. 

“Test Pass” has the meaning set forth in Section 3.05. 

  

					
		  	2	  	 Asset Representations Review Agreement

(SDART 2021-2)

 ARTICLE II. 

ENGAGEMENT; ACCEPTANCE 

Section 2.01 Engagement; Acceptance. 

The Issuer hereby engages Clayton to act as the Asset Representations Reviewer for the Issuer. Clayton hereby accepts the engagement and
agrees to perform the obligations of the Asset Representations Reviewer on the terms stated in this Agreement. 
 Section 2.02
Eligibility of Asset Representations Reviewer. 
 Clayton represents and warrants to the Issuer and the Sponsor that it is an
Eligible Asset Representations Reviewer. The Asset Representations Reviewer will notify the Issuer, the Sponsor and the Servicer promptly if it is not, or on the occurrence of any action that would result in it not being, an Eligible Asset
Representations Reviewer. 
 Section 2.03 Independence of the Asset Representations Reviewer. 

The Asset Representations Reviewer will be an independent contractor and will not be subject to the supervision of the Issuer, the Indenture
Trustee or the Owner Trustee for the manner in which it accomplishes the performance of its obligations under this Agreement. Unless expressly authorized by the Issuer, the Indenture Trustee or the Owner Trustee, the Asset Representations Reviewer
will have no authority to act for or represent the Issuer, the Indenture Trustee or the Owner Trustee, respectively, and will not be considered an agent of the Issuer, the Indenture Trustee or the Owner Trustee. Nothing in this Agreement will make
the Asset Representations Reviewer and any of the Issuer, the Indenture Trustee or the Owner Trustee members of any partnership, joint venture or other separate entity or impose any liability as such on any of them. 

ARTICLE III. 
 DUTIES OF
THE ASSET REPRESENTATIONS REVIEWER 
 Section 3.01 Review Scope. 

The parties confirm that the Asset Representations Review is not responsible for (a) reviewing the Receivables for compliance with the
representations and warranties under the Transaction Documents, except as described in this Agreement or (b) determining whether noncompliance with the representations and warranties constitutes a breach of the Eligibility Representations. For
the avoidance of doubt, the parties confirm that the review is not designed to determine why an Obligor is delinquent or the creditworthiness of the Obligor, either at the time of any Asset Review or at the time of origination of the related
Receivable. Further, the Asset Review is not designed to establish cause, materiality or recourse for any Test Fail (as defined in Section 3.05). 

  

					
		  	3	  	 Asset Representations Review Agreement

(SDART 2021-2)

 Section 3.02 Review Notices. 

Upon receipt of (i) a Review Notice from the Indenture Trustee in accordance with Section 7.6(b) of the
Indenture and (ii) the Review Materials in accordance with Section 3.03 of this Agreement, the Asset Representations Reviewer will start an Asset Review. The Asset Representations Reviewer will not be obligated to
begin, and may not begin, an Asset Review until the Asset Representations Reviewer receives a Review Notice. Within ten Business Days of receipt of a Review Notice, the Servicer shall provide the list of Subject Receivables to the Asset
Representations Reviewer in the format selected by the Servicer to the address specified in Section 9.02. 
 None
of the Issuer, the Servicer, the Sponsor or the Asset Representations Reviewer is obligated to verify whether the Indenture Trustee properly determined that a Review Notice was required. None or the Issuer, the Sponsor or the Asset Representations
Reviewer is obligated to verify the accuracy or completeness of the list of Subject Receivables provided by the Servicer. 

Section 3.03 Review Materials. 

The Servicer will provide reasonable assistance to the Asset Representations Reviewer to facilitate the Asset Review. Within 60 days of
receipt by the Servicer of the Review Notice, the Servicer will provide the Asset Representations Reviewer with the Review Materials for all Subject Receivables in one or more of the following ways, as elected by the Servicer: (i) by providing
access to the Servicer’s receivables system, either remotely or at one or more of the properties of the Servicer; (ii) by electronic posting of Review Materials to a password-protected website to which the Asset Representations Reviewer
has access; (iii) by providing originals or photocopies at one or more of the properties of the Servicer where the Receivable Files are located; (iv) by sending originals or photocopies of Review Materials to the Asset Representations
Reviewer at the address specified in Section 9.02; or (v) in another manner agreed to by the Servicer and the Asset Representations Reviewer. The Servicer may redact or remove Personally Identifiable Information from
the Review Materials so long as such redaction or removal does not result in a change in the meaning or usefulness of the Review Materials. The Asset Representations Reviewer shall not be liable for any failure of the Review Materials to be accurate
and complete, including any failure that results in the Review Materials being misleading in any material respect. 
 Section 3.04
Missing or Incomplete Review Materials. 
 The Asset Representations Reviewer will complete the Tests for each Eligible
Representation only using documentation that is made available to it. Upon receipt of the Review Materials, the Asset Representations Reviewer will complete an initial document inventory to verify there are no systemic documentation errors,
including but not limited to consistently missing or incomplete information in the Review Materials with respect to each Subject Receivable. Once the Asset Representations Reviewer has confirmed the majority of the Review Materials have been
provided in accordance with Section 3.03, the Asset Representations Reviewer will commence the Asset Review. In instances where Review Material is not accessible, clearly unidentifiable, and/or illegible, the Asset
Representations Reviewer will request that the Servicer (with a copy to the Sponsor) provide an updated copy of 

  

					
		  	4	  	 Asset Representations Review Agreement

(SDART 2021-2)

 
such Review Material. If the Servicer and the Sponsor have not provided the missing Review Material for a Subject Receivable to the Asset Representations Reviewer within 60 days of notification
by the Asset Representations Reviewer, the parties agree that such Subject Receivable will have a Test Incomplete for the related Test(s) and the Review Report will indicate the reason for the Test Incomplete. 

Section 3.05 The Asset Review. 

For an Asset Review, the Asset Representations Reviewer will perform the applicable procedures listed under “Tests” in Exhibit A for
each Eligibility Representation. In the course of its review, the Asset Representations Reviewer will use the Review Materials listed in Exhibit A. For each Test, the Asset Representations Reviewer will determine if the Test has been satisfied (a
“Test Pass”), if the Test has not been satisfied (a “Test Fail”) or if the Test could not be concluded as a result of missing or incomplete Review Materials (a “Test Incomplete”). 

If a Subject Receivable was included in a prior Asset Review, the Asset Representations Reviewer will not conduct additional Tests on any such
duplicate Subject Receivable unless such Subject Receivable was deemed a Test Incomplete as a result of the failure of the Servicer and the Sponsor to provide missing Review Materials for such Subject Receivable and the Sponsor elects to have such
Subject Receivable included in the current Asset Review. The Asset Representations Reviewer will include the previously reported Test results for any such duplicate Subject Receivable within the Review Report for the current Asset Review. 

Section 3.06 Review Period. 

The Asset Representations Reviewer will complete the Review within 60 days of receiving access to the Review Materials in accordance with
Section 3.03 (such time period, the “Review Period”); provided, that if additional Review Materials are provided to the Asset Representations Reviewer as described in
Section 3.04, the Review Period will be extended for an additional 30 days. 
 Section 3.07 Review
Report. 
 Within five Business Days following the end of the applicable Review Period described in
Section 3.06, the Asset Representations Reviewer will provide the Issuer, the Sponsor, the Servicer and the Indenture Trustee with (i) a report (a “Review Report”) specifying for each Subject
Receivable whether there was a Test Pass, a Test Fail, a Test Incomplete (as contemplated by Section 3.05) or a Test Complete (as contemplated by Section 3.08) for each Test and Subject Receivable
and (ii) the related Review Invoice. The Review Report will include a summary of the findings and conclusions of the Asset Representations Reviewer with respect to the Asset Review to be included in the Form
10-D for the Issuer for the Collection Period in which the Review Report is received. The Asset Representations Reviewer will ensure that the Review Report does not contain any Personally Identifiable
Information. For the avoidance of doubt, the Indenture Trustee shall have no obligation to forward the Review Report to any Noteholder or any other person. 

  

					
		  	5	  	 Asset Representations Review Agreement

(SDART 2021-2)

 Section 3.08 Completion of Review for Certain Subject Receivables. 

Following the delivery of the list of the Subject Receivables and before the delivery of the Review Report by the Asset Representations
Reviewer, the Servicer may notify the Asset Representations Reviewer if a Subject Receivable is paid in full by or on behalf of the Obligor or purchased from the Issuer by the Sponsor or the Servicer in accordance with the Transaction Documents. On
receipt of notice, the Asset Representations Reviewer will immediately terminate all Tests of such Receivables and the Asset Review of such Receivables will be considered complete (a “Test Complete”). In this case, the Review Report
will indicate a Test Complete for the Receivables and the related reason. 
 Section 3.09 Termination of Review. 

If an Asset Review is in process and the Notes will be paid in full on the next Payment Date (including any payment in full as a result of any
early redemption of the Notes), the Servicer will notify the Asset Representations Reviewer and the Indenture Trustee no less than ten days before that Payment Date. On receipt of notice, the Asset Representations Reviewer will terminate the Asset
Review immediately and will not be obligated to deliver a Review Report. 
 Section 3.10 Review and Procedure Limitations. 

The Asset Representations Reviewer will have no obligation (i) to determine whether a Delinquency Trigger has occurred, (ii) to
determine whether the required percentage of Noteholders has voted to direct an Asset Review and may rely on the information in any Review Notice delivered by the Indenture Trustee, (iii) to determine which Receivables are Subject Receivables
and may rely on the list of Subject Receivables provided by the Servicer, (iv) to confirm the validity of the Review Materials, (v) other than as specified in Section 3.03, to obtain missing or insufficient Review
Materials, or (vi) to take any action or to cause any other party to take any action under any of the Transaction Documents to enforce any remedies for any breach of a representation, warranty or covenant, including any Eligibility
Representation. 
 The Asset Representations Reviewer shall only be required to perform the testing procedures listed under
“Tests” in Exhibit A, and shall have no obligation to perform additional testing procedures on any Subject Receivables or to consider any additional information provided by any party. The Asset Representations Reviewer shall have no
obligation to provide reporting or other information other than the Review Report described in Section 3.07. However, the Asset Representations Reviewer may provide additional information about any Subject Receivable that
it determines in good faith to be material to its performance of an Asset Review. 
 Section 3.11 Review Systems. 

The Asset Representations Reviewer shall maintain and utilize an electronic case management system to manage the Tests and to provide
systematic control over each step in the Asset Review process and ensure consistency and repeatability for the Tests. The Asset Representations Reviewer will ensure that these systems allow for each Subject Receivable and the related Review
Materials to be individually tracked and stored as contemplated by this Agreement. The Asset Representations Reviewer will maintain adequate staff that is properly trained to conduct Asset Reviews as required by this Agreement. 

  

					
		  	6	  	 Asset Representations Review Agreement

(SDART 2021-2)

 Section 3.12 Representatives. 

(a) Servicer Representative. The Servicer will provide reasonable access to one or more designated representatives to respond to
reasonable requests and inquiries made by the Asset Representations Reviewer in its completion of an Asset Review. 
 (b) Asset
Representations Review Representative. The Asset Representations Reviewer will provide reasonable access to one or more designated representatives to respond to reasonable requests and inquiries made by the Servicer, the Sponsor, the Issuer or
the Indenture Trustee during the Asset Representations Reviewer’s completion of an Asset Review. The Asset Representations Reviewer shall have no obligation to respond to requests or inquires, and other than as specified in
Section 3.13 shall not respond to requests or inquiries, made by any Person not party to this Agreement other than the Indenture Trustee; provided, that if the Asset Representations Reviewer receives any request or
inquiry from a Person not a party to this Agreement, then the Asset Representations Reviewer may inform such Person that they may contact the Servicer and/or the Indenture Trustee with respect to such request or inquiry. 

Section 3.13 Dispute Resolution. 

If a Subject Receivable that was reviewed by the Asset Representations Reviewer during an Asset Review is the subject of a dispute resolution
proceeding under Section 9.24 of the Sale and Servicing Agreement, the Asset Representations Reviewer shall participate in the dispute resolution proceeding on request of a party to the proceeding. The reasonable out-of-pocket expenses and reasonable compensation of the Asset Representations Reviewer for its participation in any dispute resolution proceeding will be considered expenses
of the Requesting Party for the dispute resolution and (subject to Section 4.03) will be paid by a party to the dispute resolution as determined by the mediator or arbitrator for the dispute resolution according to
Section 9.24 of the Sale and Servicing Agreement. 
 Section 3.14 Records Retention. 

The Asset Representations Reviewer will maintain copies of Review Materials, Review Reports and internal work papers and correspondence
(collectively the “Client Records”) for a period of two years after the termination of this Agreement. At the expiration of the retention period, the Asset Representations Reviewer shall return all Client Records to the Servicer, in
electronic format or, to the extent held in tangible form, in that form. Upon the return of the Client Records, the Asset Representations Reviewer shall have no obligation to retain such Client Records or to respond to inquiries concerning any Asset
Review. 
 Section 3.15 No Delegation. 

The Asset Representations Reviewer may not delegate or subcontract its obligations under this Agreement to any Person without the consent of
the Issuer, the Sponsor and the Servicer. 

  

					
		  	7	  	 Asset Representations Review Agreement

(SDART 2021-2)

 ARTICLE IV. 

PAYMENTS TO ASSET REPRESENTATIONS REVIEW 

Section 4.01 Annual Fee. 

As compensation for its activities hereunder, the Asset Representations Reviewer shall be entitled to receive an annual fee in an amount equal
to $5,000 (the “Annual ARR Fee”) during the term of this Agreement, which shall be paid by or on behalf of the Sponsor within 30 days of the date hereof, with respect to the initial Annual ARR Fee, and within 30 days of the annual
anniversary of this Agreement with respect to each subsequent Annual ARR Fee; provided, however, that if the Asset Representations Reviewer resigns or is removed in accordance with Section 6.02, then the Asset
Representations Reviewer shall refund to the Sponsor the portion of the Annual ARR Fee attributable to the portion of the annual period during which Clayton will no longer act as the Asset Representations Reviewer, assuming for purposes of such
calculation that the Annual ARR Fee for each day during the annual period is an amount equal to the Annual ARR Fee divided by 365. 

Section 4.02 Review Fee. 

Following the completion of an Asset Review and delivery to the Indenture Trustee, the Sponsor, the Servicer and the Issuer of the Review
Report and the related Review Invoice, the Sponsor shall pay to the Asset Representations Reviewer a fee of $200.00 for each Subject Receivable for which the Asset Review was completed plus reasonable out-of-pocket expenses incurred in connection with travel to the location at which Review Materials are made available in accordance with Section 3.03 (the “Review
Fee”). However, no Review Fee will be charged for any Subject Receivable which was included in a prior Asset Review or for which no Tests were completed prior to the Asset Representations Reviewer being notified of a termination of the
Asset Review according to Section 3.09. To the extent not paid by the Sponsor and outstanding for at least 90 days after receipt by the Indenture Trustee, the Sponsor, the Servicer and the Issuer of the Review Invoice, the
Review Fee shall be paid by the Issuer pursuant to the priority of payments sets forth in Section 4.4 of the Sale and Servicing Agreement or Section 5.4(b) of the Indenture, as applicable. For the
avoidance of doubt, there shall be no aggregate limit on the Review Fee paid by the Sponsor to the Asset Representations Reviewer pursuant to this Section 4.02. 

Section 4.03 Dispute Resolution Expenses. 

If the Asset Representations Reviewer participates in a dispute resolution proceeding under Section 3.13 and its
reasonable out-of-pocket expenses and reasonable compensation for the time it incurs in participating in the proceeding are not paid by a party to the dispute resolution
within ninety (90) days of the end of the proceeding, the Sponsor will reimburse the Asset Representations Reviewer for such expenses upon receipt of a detailed invoice. 

  

					
		  	8	  	 Asset Representations Review Agreement

(SDART 2021-2)

 Section 4.04 Payment. 

All payments made to the Asset Representations Reviewer shall be made to the account specified by the Asset Representations Reviewer from time
to time in writing to the Indenture Trustee, the Sponsor, the Servicer and the Issuer. 
 Section 4.05 Payments by the Issuer.

 The Asset Representations Reviewer acknowledges and agrees that any payments payable by the Issuer under this Agreement, including
pursuant to this Article IV or Section 5.03, shall be limited to amounts available to make such payments pursuant to Section 4.4 of the Sale and Servicing Agreement and
Section 5.4(b) of the Indenture, as applicable. 
 ARTICLE V. 

OTHER MATTERS PERTAINING TO THE ASSET REPRESENTATIONS REVIEWER 

Section 5.01 Representations and Warranties of the Asset Representations Reviewer. 

Clayton hereby makes the following representations and warranties as of the date hereof: 

(a) Existence and Power. Clayton is a limited liability company validly existing and in good standing under the laws of its state of
formation and has, in all material respects, full power and authority to own its assets and operate its business as presently owned or operated, and to execute, to deliver and to perform its obligations under this Agreement. Clayton has obtained all
necessary licenses and approvals in each jurisdiction where the failure to do so would materially and adversely affect the ability of Clayton to perform its obligations under this Agreement. 

(b) Authorization and No Contravention. The execution, delivery and performance by Clayton of the Transaction Documents to which it is
a party have been duly authorized by all necessary limited liability company action on the part of Clayton and do not contravene or constitute a default under (i) any applicable law, rule or regulation, (ii) its organizational documents or
(iii) any material indenture or material agreement or instrument to which Clayton is a party or by which its properties are bound (other than violations of such laws, rules, regulations, organizational documents, indentures, agreements or
instruments which do not affect the legality, validity or enforceability of any of such agreements and which, individually or in the aggregate, would not materially and adversely affect the transactions contemplated by, or Clayton’s ability to
perform its obligations under, this Agreement). 
 (c) No Consent Required. No approval or authorization by, or filing with, any
Governmental Authority is required in connection with the execution, delivery and performance by Clayton of this Agreement other than (i) approvals and authorizations that have previously been obtained and filings that have previously been made
and (ii) approvals, authorizations or filings which, if not obtained or made, would not have a material adverse effect on the ability of Clayton to perform its obligations under this Agreement. 

(d) Binding Effect. This Agreement constitutes the legal, valid and binding obligation of Clayton enforceable against Clayton in
accordance with its terms, except as such enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium, receivership, conservatorship or other similar laws affecting the enforcement of creditors’ rights
generally and, if applicable, the rights of creditors of corporations from time to time in effect or by general principles of equity. 

  

					
		  	9	  	 Asset Representations Review Agreement

(SDART 2021-2)

 (e) No Proceedings. There are no actions, orders, suits or proceedings pending or, to
the knowledge of Clayton, threatened against Clayton before or by any Governmental Authority that (i) assert the invalidity or unenforceability of this Agreement or (ii) seek any determination or ruling that would materially and adversely
affect the performance by Clayton of its obligations under this Agreement. 
 (f) Eligibility. The Asset Representations Reviewer is
an Eligible Asset Representations Reviewer. 
 Section 5.02 Limitation of Liability of Asset Representations Reviewer. 

To the fullest extent permitted by applicable law, the Asset Representations Reviewer shall not be under any liability to the Issuer, the
Servicer, the Depositor, the Indenture Trustee, the Owner Trustee, any Noteholder or any other Person for any action taken or for refraining from the taking of an action in its capacity as Asset Representations Reviewer pursuant to this Agreement,
or for errors in judgment, whether arising from express or implied duties under this Agreement; provided, however, that this provision shall not protect the Asset Representations Reviewer against any liability which would otherwise be
imposed by reason of willful misconduct, bad faith, breach of this Agreement or negligence in the performance of its duties. In no event will the Asset Representations Reviewer be liable for special, indirect or consequential loss or damage
(including loss of profit) even if the Asset Representations Reviewer has been advised of the likelihood of the loss or damage and regardless of the form of action. 

The Asset Representations Reviewer and any director, officer, employee, or agent may rely in good faith on any document of any kind prima
facie properly executed and submitted by any Person respecting any matters arising hereunder. The Asset Representations Reviewer shall not be under any obligation to appear in, prosecute or defend any legal action which is not incidental to its
duties as Asset Representations Reviewer hereunder. 
 Section 5.03 Indemnification of Asset Representations Reviewer. 

(a) The Sponsor will indemnify the Asset Representations Reviewer and its officers, directors, employees and agents (each, an
“Indemnified Person”), for all costs, expenses, losses, damages and liabilities resulting from the performance of the Asset Representations Reviewer’s obligations under this Agreement (including the costs and expenses of
defending itself against any loss, damage or liability), but excluding any cost, expense, loss, damage or liability resulting from (i) the Asset Representations Reviewer’s willful misconduct, bad faith or negligence or (ii) the Asset
Representations Reviewer’s breach of any of its representations, warranties or covenants in this Agreement. To the extent not paid by the Sponsor, any such indemnification amounts shall be paid by the Issuer pursuant to the priority of payments
set forth in Section 4.4 of the Sale and Servicing Agreement or Section 5.4(b) of the Indenture, as applicable. 

  

					
		  	10	  	 Asset Representations Review Agreement

(SDART 2021-2)

 (b) The indemnification set forth in this Section 5.03 will
survive the termination of this Agreement and the resignation or removal of the Asset Representations Reviewer. 
 (c) If the Sponsor or the
Issuer makes any payment under this Section 5.03 and the Indemnified Person later collects any of the amounts for which the payments were made to it from others, the Indemnified Person will promptly repay the amount to the
Sponsor or the Issuer, as applicable. 
 Section 5.04 Indemnification by Asset Representations Reviewer. 

(a) To the fullest extent permitted by law, the Asset Representations Reviewer shall indemnify and hold harmless each of the Issuer, the Owner
Trustee, the Servicer, the Sponsor and the Indenture Trustee, and its officers, directors, successors, assigns, legal representatives, agents, and servants (each an “Indemnified Person”), from and against any and all liabilities,
obligations, losses, damages, penalties, taxes, claims, actions, investigations, proceedings, costs, expenses or disbursements (including reasonable legal fees and expenses) of any kind and nature whatsoever which may be imposed on, incurred by, or
asserted at any time against an Indemnified Person (whether or not also indemnified against by any other person) which arose out of the negligence, willful misconduct or bad faith of the Asset Representations Reviewer in the performance of its
obligations and duties under this Agreement; provided, however, that the Asset Representations Reviewer shall not be liable for or required to indemnify an Indemnified Person from and against expenses arising or resulting from
(i) the Indemnified Person’s own willful misconduct, bad faith or negligence, or (ii) the breach of any representation, warranty or covenant made by the Indemnified Person. 

(b) In case any such action, investigation or proceeding will be brought involving an Indemnified Person as contemplated by
Section 5.04(a), the Asset Representations Reviewer will assume the defense thereof, including the employment of counsel and the payment of all expenses. The Issuer, the Servicer, the Sponsor and the Indenture Trustee each
will have the right to employ separate counsel in any such action, investigation or proceeding and to participate in the defense thereof and the reasonable fees and expenses of such counsel will be paid by the Asset Representations Reviewer. In the
event of any claim, action, or proceeding for which indemnity will be sought pursuant to this Section 5.04, the Issuer’s, the Servicer’s, the Sponsor’s and the Indenture Trustee’s choice of legal counsel
shall be subject to the good faith objection by the Asset Representations Reviewer to a conflict of interest under the applicable rules of professional conduct. 

(c) The indemnification set forth in this Section 5.04 will survive the termination or assignment of this Agreement
and the resignation or removal of the Asset Representations Reviewer or any Indemnified Person. 
 ARTICLE VI. 

REMOVAL, RESIGNATION; SUCCESSOR ASSET REPRESENTATION REVIEWER 

Section 6.01 Eligibility Requirements for Asset Representations Reviewer. The Asset Representations Reviewer must be an Eligible
Asset Representations Reviewer. 

  

					
		  	11	  	 Asset Representations Review Agreement

(SDART 2021-2)

 Section 6.02 Resignation and Removal of Asset Representations Reviewer. 

(a) No Resignation of Asset Representations Reviewer. The Asset Representations Reviewer may not resign as Asset Representations
Reviewer except (i) if the Asset Representations Reviewer is no longer an Eligible Asset Representations Reviewer, (ii) upon a determination that the performance of its duties under this Agreement is no longer permissible under applicable
law or (iii) if it does not receive payment in full of any amounts required to be paid to the Asset Representations Reviewer in accordance with Article IV and pursuant to an undisputed invoice, which failure continues unremedied for a period of
ninety (90) days after written notice of such failure shall have been given to the Issuer, the Sponsor and the Indenture Trustee. Without limiting the foregoing, the Asset Representations Review shall promptly resign if it is no longer an
Eligible Asset Representations Reviewer. If the Asset Representations Reviewer resigns pursuant to clause (ii) above, the Asset Representations Reviewer shall deliver a notice of resignation to the Issuer and the Servicer, with a copy to the
Indenture Trustee, no less than thirty (30) days prior to the date of its resignation. 
 (b) Removal of Asset Representations
Reviewer. If any of the following events occur, the Indenture Trustee may, or, at the direction of Noteholders evidencing a majority of the aggregate Outstanding Amount of the Notes shall, by notice to the Asset Representations Reviewer, remove
the Asset Representations Reviewer and terminate its rights and obligations under this Agreement: 
 (i) the Asset
Representations Reviewer is no longer an Eligible Asset Representations Reviewer; 
 (ii) the Asset Representations Reviewer
breaches any of its representations, warranties, covenants or obligations in this Agreement; or 
 (iii) a Bankruptcy Event
of the Asset Representations Reviewer occurs. 
 (c) Notice of Resignation or Removal. The Servicer will notify the Issuer, the Owner
Trustee and the Indenture Trustee of any resignation or removal of the Asset Representations Reviewer. 
 Section 6.03 Successor
Asset Representations Reviewer. 
 (a) Engagement of Successor Asset Representations Reviewer. Following the resignation or
removal of the Asset Representations Reviewer, (i) if the Delinquency Percentage has exceeded the Delinquency Trigger as of the most recent Payment Date, the Indenture Trustee (at the direction of the Noteholders, provided, that if the
Indenture Trustee has received conflicting or inconsistent requests from two or more groups of Noteholders, each representing less than the majority of the Note Balance, the Indenture Trustee shall follow the direction of the Noteholders
representing the greater percentage of the Note Balance) and (ii) if the Delinquency Percentage has not exceeded the Delinquency Trigger as of the most recent Payment Date, the Sponsor, will appoint a successor Asset Representations Reviewer
which is an Eligible Asset Representations Reviewer. 

  

					
		  	12	  	 Asset Representations Review Agreement

(SDART 2021-2)

 (b) Effectiveness of Resignation or Removal. No resignation or removal of the Asset
Representations Reviewer will be effective until the successor Asset Representations Reviewer has executed and delivered to the Issuer, the Sponsor and the Servicer an agreement accepting its engagement and agreeing to perform the obligations of the
Asset Representations Reviewer under this Agreement or entered into a new agreement with the Issuer, the Sponsor and the Servicer on substantially the same terms as this Agreement. 

(c) Transition and Expenses. If the Asset Representations Review resigns or is removed, the Asset Representations Reviewer will
cooperate with the Issuer and take all actions reasonably requested to assist the Issuer in making an orderly transition of the Asset Representations Reviewer’s rights and obligations under this Agreement to the successor Asset Representations
Reviewer. The Asset Representations Reviewer will pay the reasonable expenses (including the fees and expenses of counsel) of transitioning the Asset Representations Reviewer’s obligations under this Agreement and preparing the successor Asset
Representations Reviewer to take on such obligations on receipt of an invoice with reasonable detail of the expenses from the Issuer or the successor Asset Representations Reviewer. 

Section 6.04 Merger, Consolidation or Succession. Any Person (a) into which the Asset Representations Reviewer is merged or
consolidated, (b) resulting from any merger or consolidation to which the Asset Representations Reviewer is a party or (c) succeeding to the business of the Asset Representations Reviewer, if that Person is an Eligible Asset
Representations Reviewer, will be the successor to the Asset Representations Reviewer under this Agreement. Such Person will execute and deliver to the Issuer, the Sponsor and the Servicer an agreement to assume the Asset Representations
Reviewer’s obligations under this Agreement (unless the assumption happens by operation of law). 
 ARTICLE VII. 

TREATMENT OF CONFIDENTIAL INFORMATION 

Section 7.01 Confidential Information. 

(a) Confidential Information Defined. For the purposes of this Agreement, “Confidential Information” means nonpublic
proprietary information of a party (the “Disclosing Party”) that is disclosed to the other party (the “Receiving Party”), including but not limited to: (i) business or technical processes, formulae, source
codes, object code, product designs, sales, cost and other unpublished financial information, customer information, product and business plans, projections, marketing data or strategies, trade secrets, intellectual property rights, know-how, expertise, methods and procedures for operation, information about employees, customer names, business or technical proposals, and any other information which is or should reasonably be understood to be
confidential or proprietary to the Disclosing Party; (ii) PII (as defined in Section 7.02 of this Agreement). The foregoing definition of Confidential Information applies to: (i) all such information, whether
tangible or intangible and regardless of the medium in which it is stored or presented; and (ii) all copies of such information, as well as all memoranda, notes, summaries, analyses, computer records, and other materials prepared by the
Receiving Party or any of its employees, agents, advisors, directors, officers, and subcontractors (collectively “Representatives”) that contain or reflect the Confidential Information. 

  

					
		  	13	  	 Asset Representations Review Agreement

(SDART 2021-2)

 (b) Use of Confidential Information. Each party acknowledges that during the term of
this Agreement it may be exposed to or acquire Confidential Information of the other party or its Affiliates. The Receiving Party shall hold the Confidential Information of the Disclosing Party in strict confidence and will not disclose such
information except to its Representatives who have a need to know such information for the purpose of effecting the terms and conditions of this Agreement and who have entered into an agreement with the Receiving Party with confidentiality
restrictions materially equivalent to those contained herein. The Receiving Party shall be responsible for the breach of this Agreement by any of its Representatives. The Receiving Party will protect the Disclosing Party’s Confidential
Information using the same degree of care that it uses to protect its own information of like import, but in no event with less than a commercially reasonable standard of care. 

(c) Exceptions. Confidential Information shall not include, and this Agreement imposes no obligations with respect to, information
that: 
  

	 	(i)	 is or becomes part of the public domain other than by disclosure by a party in violation of this Agreement;

  

	 	(ii)	 was disclosed to a party prior to the effective date of this Agreement without a duty of confidentiality;

  

	 	(iii)	 is independently developed by a party outside of this Agreement and without reference to or reliance on any
Confidential Information of the other party; or 

  

	 	(iv)	 was obtained from a third party not known after reasonable inquiry to be under a duty of confidentiality.

 The foregoing exceptions shall not apply to any PII, which shall remain confidential in all circumstances, except as
required or permitted to be disclosed by applicable law, statute, or regulation. 
 (d) Disclosure by Operation of Law. If either
party is requested to disclose all or any part of any Confidential Information under a subpoena, or inquiry issued by a court of competent jurisdiction or by a judicial or administrative agency or legislative body or committee, such party shall
(i) to the extent permitted by law, promptly notify the other party of the existence, terms and circumstances surrounding such request; (ii) consult with the other party on the advisability of taking legally available steps to resist or
narrow such request and cooperate with such Party on any steps it considers advisable; and (iii) if disclosure of the Confidential Information is required or deemed advisable, exercise commercially reasonable efforts to obtain an order,
stipulation or other reliable assurance that confidential treatment shall be accorded to such portion of the Confidential Information to be disclosed. Each party shall reimburse the other party for reasonable legal fees and expenses incurred in
connection with such party’s effort to comply with this section. 
 (e) Return of Confidential Information. Upon the request of
the Disclosing Party, the Receiving Party shall return all Confidential Information to the Disclosing Party provided to it pursuant to this Agreement; provided, however, (i) the Receiving Party shall be permitted to

  

					
		  	14	  	 Asset Representations Review Agreement

(SDART 2021-2)

 
retain copies of the Disclosing Party’s Confidential Information solely for archival, audit, disaster recovery, legal and/or regulatory purposes, and (ii) neither party will be required
to search archived electronic back-up files of its computer systems for the other party’s Confidential Information in order to purge the other party’s Confidential Information from its archived
files; provided further, that any Confidential Information so retained will (x) remain subject to the obligations and restrictions contained in this Agreement, (y) will be maintained in accordance with the retaining party’s document
retention policies and procedures, and (z) the retaining party will not use the retained Confidential Information for any other purpose. 

(f) Remedies. The parties agree that an actual or threatened breach of this Section by it or its Representatives may cause irreparable
damage to the Disclosing Party and that damages may not be an adequate remedy for any such breach. Accordingly, each party shall be entitled to seek injunctive relief to restrain any such breach, threatened or actual, without the necessity of
posting bond, in addition to any other remedies available to such party at law or in equity. 
 Section 7.02 Safeguarding Personally
Identifiable Information. 
 (a) Definition. “Personally Identifiable Information”, or “PII”,
means information in any format about an identifiable individual, including, name, address, phone number, e-mail address, account number(s), identification number(s), any other actual or assigned attribute
associated with or identifiable to an individual and any information that when used separately or in combination with other information could identify an individual, as further described in § 501(b) of the Gramm-Leach-Bliley Act and the
Interagency Guidelines Establishing Standards for Safeguarding Customer Information (12 C.F.R. Section 208, Appendix D-2) (collectively, the “Privacy Laws”), that is provided or made
available to the Asset Representations Reviewer pursuant to this Agreement. 
 (b)
Non-Disclosure. To the extent the Asset Representations Reviewer receives Personally Identifiable Information in the performance its obligations hereunder, the Asset Representations Reviewer agrees that
it will not disclose or use any Personally Identifiable Information except (i) to the extent necessary to carry out its obligations under the Agreement and for no other purpose; or (ii) as may be required by valid operation of law. 

(c) Safeguards. To the extent the Asset Representations Reviewer receives Personally Identifiable Information in the performance of
services under this Agreement, the Asset Representations Reviewer represents and warrants that it has, and will continue to have adequate administrative, technical, and physical safeguards: (i) to ensure the security and confidentiality of
Personally Identifiable Information; (ii) to protect against any anticipated threats or hazards to the security or integrity of Personally Identifiable Information; and (iii) to protect against unauthorized acquisition of, access to or use
of Personally Identifiable Information which could result in a “breach” as that term is defined under applicable Privacy Laws. 

(d) Information. The Asset Representations Reviewer agrees to provide the Issuer and the Sponsor with information regarding its privacy
and information security systems, policies and procedures as the Issuer may reasonably request relating to compliance with this Agreement and applicable Privacy Laws. The Asset Representations Reviewer agrees to provide training in the Privacy Laws
and the Asset Representations Reviewer’s information security policies to all personnel whose duties pursuant to this Agreement could bring them in contact with Personally Identifiable Information. 

  

					
		  	15	  	 Asset Representations Review Agreement

(SDART 2021-2)

 (e) Breach. In the event of any actual or apparent theft, unauthorized use or
disclosure of any Personally Identifiable Information, the Asset Representations Reviewer will commence all reasonable efforts to investigate and correct the causes and remediate the results thereof, and as soon as practicable following discovery of
any such event, provide the Issuer and the Sponsor notice thereof, and such further information and assistance as may be reasonably requested. 

ARTICLE VIII. 
 OTHER
MATTERS PERTAINING TO THE ISSUER 
 Section 8.01 Termination of this Agreement. This Agreement will terminate, except for
obligations under Section 5.03, Section 5.04, Section 9.13 and Article VII, on the earlier of (a) the payment in full of all outstanding Notes and the
satisfaction and discharge of the Indenture and (b) the date the Issuer is terminated under the Trust Agreement. 
 Section 8.02
Limitation of Liability. It is expressly understood and agreed by the parties that (a) this document is executed and delivered by Wilmington Trust, National Association, not individually or personally, but solely as Owner Trustee of the
Issuer, in the exercise of the powers and authority conferred and vested in it, pursuant to the Trust Agreement, (b) each of the representations, warranties, covenants, undertakings and agreements herein made on the part of the Issuer is made
and intended not as personal representations, warranties, covenants undertakings and agreements by Wilmington Trust, National Association, but is made and intended for the purpose of binding only the Issuer, (c) nothing herein contained shall
be construed as creating any liability on Wilmington Trust, National Association, individually or personally, to perform any covenant either expressed or implied contained herein, all such liability, if any, being expressly waived by the parties
hereto and by any person claiming by, through or under the parties hereto, (d) Wilmington Trust, National Association has made no investigation as to the accuracy or completeness of any representations or warranties made by the Issuer or any
other Person in this Agreement and (e) under no circumstances shall Wilmington Trust, National Association be personally liable for the payment of any indebtedness, indemnities or expenses of the Issuer or be liable for the breach or failure of
any obligation, representation, warranty or covenant made or undertaken by the Issuer under this Agreement or under the Notes or any of the other Transaction Documents or in any of the certificates, notices or agreements delivered pursuant thereto,
as to all of which recourse shall be had solely to the assets of the Issuer. 

  

					
		  	16	  	 Asset Representations Review Agreement

(SDART 2021-2)

 ARTICLE IX. 

MISCELLANEOUS PROVISIONS 

Section 9.01 Amendment. 

(a) Any term or provision of this Agreement may be amended by the Sponsor, the Servicer and the Asset Representations Reviewer without the
consent of the Indenture Trustee, any Noteholder, the Issuer, the Owner Trustee or any other Person subject to the satisfaction of one of the following conditions: 

(i) the Sponsor or the Servicer delivers an Opinion of Counsel to the Indenture Trustee to the effect that such amendment will
not materially and adversely affect the interests of the Noteholders; or 
 (ii) the Rating Agency Condition is satisfied
with respect to such amendment and the Sponsor or the Servicer notifies the Indenture Trustee in writing that the Rating Agency Condition is satisfied with respect to such amendment; 

provided, that no amendment pursuant to this Section 9.01(a) shall be effective which affects the rights, protections or
duties of the Indenture Trustee or the Owner Trustee without the prior written consent of such Person. 
 (b) This Agreement may also be
amended from time to time by the Sponsor, the Servicer and the Asset Representations Reviewer, with the consent of the Holders of Notes evidencing not less than a majority of the aggregate principal amount of the Controlling Class, for the purpose
of adding any provisions to or changing in any manner or eliminating any of the provisions of this Agreement or of modifying in any manner the rights of the Noteholders, provided, that no amendment pursuant to this
Section 9.01(b) shall be effective which affects the rights, protections or duties of the Indenture Trustee or the Owner Trustee without the prior written consent of such Person. It will not be necessary for the consent of
Noteholders to approve the particular form of any proposed amendment or consent, but it will be sufficient if such consent approves the substance thereof. The manner of obtaining such consents (and any other consents of Noteholders provided for in
this Agreement) and of evidencing the authorization of the execution thereof by Noteholders will be subject to such reasonable requirements as the Indenture Trustee may prescribe, including the establishment of record dates pursuant to the
Depository Agreement. 
 (c) Any term or provision of this Agreement may also be amended from time to time by the Sponsor, the Servicer and
the Asset Representations Reviewer for the purpose of conforming the terms of this Agreement to the description thereof in the Prospectus or, to the extent not contrary to the Prospectus, to the description thereof in an offering memorandum with
respect to the 144A Notes or the Certificates without the consent of the Indenture Trustee, any Noteholder, the Issuer, the Owner Trustee or any other Person, provided, however, that the Sponsor, the Servicer and the Asset
Representations Reviewer shall provide written notification of the substance of such amendment to the Indenture Trustee, the Issuer and the Owner Trustee and promptly after the execution of such amendment, the Sponsor and the Servicer shall furnish
a copy of such amendment to the Indenture Trustee, the Issuer and the Owner Trustee. 

  

					
		  	17	  	 Asset Representations Review Agreement

(SDART 2021-2)

 (d) Prior to the execution of any amendment or consent pursuant to this
Section 9.01, the Sponsor shall provide written notification of the substance of such amendment to each Rating Agency; and promptly after the execution of any such amendment or consent, the Sponsor shall furnish a copy of
such amendment or consent to each Rating Agency and the Indenture Trustee. 
 (e) Prior to the execution of any amendment to this Agreement,
the Owner Trustee and the Indenture Trustee shall be entitled to receive and conclusively rely upon an Opinion of Counsel stating that the execution of such amendment is authorized or permitted by this Agreement and that all conditions precedent to
the execution and delivery of such amendment have been satisfied. The Owner Trustee and the Indenture Trustee may, but shall not be obligated to, enter into any such amendment which adversely affects the Owner Trustee’s or the Indenture
Trustee’s, as applicable, own rights, duties or immunities under this Agreement. 
 Section 9.02 Notices, Etc. All demands,
notices and communications hereunder shall be in writing and shall be delivered or mailed by registered or certified first-class United States mail, postage prepaid, hand delivery, prepaid courier service, or by facsimile or by electronic
transmission, and addressed in each case as specified on Schedule I to the Sale and Servicing Agreement or at such other address as shall be designated by any of the specified addressees in a written notice to the other parties hereto.
Delivery shall occur only upon receipt or reported tender of such communication by an officer of the recipient entitled to receive such notices located at the address of such recipient for notices hereunder. 

Section 9.03 Severability Clause. 

This Agreement constitutes the entire agreement between the Asset Representations Reviewer, the Issuer, Servicer, and the Sponsor. All prior
representations, statements, negotiations and undertakings with regard to the subject matter hereof are superseded hereby. 
 If any term or
provision of this Agreement or the application thereof to any person or circumstance shall, to any extent, be invalid or unenforceable, the remaining terms and provisions of this Agreement, or the application of such terms or provisions to persons
or circumstances other than those as to which it is held invalid or unenforceable, shall not be affected thereby, and each term and provision of this Agreement shall be valid and enforced to the fullest extent permitted by law. 

Section 9.04 Governing Law. THIS AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE INTERNAL, SUBSTANTIVE LAWS OF
THE STATE OF NEW YORK WITHOUT REFERENCE TO THE RULES THEREOF RELATING TO CONFLICTS OF LAW, OTHER THAN SECTIONS 5-1401 AND 5-1402 OF THE NEW YORK GENERAL OBLIGATIONS LAW,
AND THE OBLIGATIONS, RIGHTS AND REMEDIES OF THE PARTIES HEREUNDER SHALL BE DETERMINED IN ACCORDANCE WITH SUCH LAWS. 

  

					
		  	18	  	 Asset Representations Review Agreement

(SDART 2021-2)

 Section 9.05 Headings. The article and section headings hereof have been
inserted for convenience only and shall not be construed to affect the meaning, construction or effect of this Agreement. 

Section 9.06 Counterparts and Electronic Signature. This Agreement shall be valid, binding, and enforceable against a party only
when executed by an authorized individual on behalf of the party by means of (i) an electronic signature that complies with the federal Electronic Signatures in Global and National Commerce Act, state enactments of the Uniform Electronic
Transactions Act, and/or any other relevant electronic signatures law, in each case to the extent applicable; (ii) an original manual signature; or (iii) a faxed, scanned, or photocopied manual signature. Each electronic signature or
faxed, scanned, or photocopied manual signature shall for all purposes have the same validity, legal effect, and admissibility in evidence as an original manual signature. Each party hereto shall be entitled to conclusively rely upon, and shall have
no liability with respect to, any electronic signature or faxed, scanned, or photocopied manual signature of any other party and shall have no duty to investigate, confirm or otherwise verify the validity or authenticity thereof. This Agreement may
be executed in any number of counterparts, each of which shall be deemed to be an original, but such counterparts shall, together, constitute only one instrument. Notwithstanding the foregoing, with respect to any notice provided for in this
Agreement or any instrument required or permitted to be delivered hereunder, any party hereto receiving or relying upon such notice or instrument shall be entitled to request execution thereof by original manual signature as a condition to the
effectiveness thereof. 
 Section 9.07 Waivers. No failure or delay on the part of the Sponsor, the Servicer, the Asset
Representations Reviewer, the Issuer or the Indenture Trustee in exercising any power or right hereunder (to the extent such Person has any power or right hereunder) shall operate as a waiver thereof, nor shall any single or partial exercise of any
such power or right preclude any other or further exercise thereof or the exercise of any other power or right. No notice to or demand on the any party hereto in any case shall entitle it to any notice or demand in similar or other circumstances. No
waiver or approval by either party under this Agreement shall, except as may otherwise be stated in such waiver or approval, be applicable to subsequent transactions. No waiver or approval under this Agreement shall require any similar or dissimilar
waiver or approval thereafter to be granted hereunder. 
 Section 9.08 Entire Agreement. This Agreement contains a final and
complete integration of all prior expressions by the parties hereto with respect to the subject matter thereof and shall constitute the entire agreement among the parties hereto with respect to the subject matter thereof, superseding all prior oral
or written understandings. There are no unwritten agreements among the parties. 
 Section 9.09 Severability of Provisions. If
any one or more of the covenants, agreements, provisions or terms of this Agreement shall be for any reason whatsoever held invalid, then such covenants, agreements, provisions or terms shall be deemed severable from the remaining covenants,
agreements, provisions or terms of this Agreement and shall in no way affect the validity or enforceability of the other provisions of this Agreement. 

  

					
		  	19	  	 Asset Representations Review Agreement

(SDART 2021-2)

 Section 9.10 Binding Effect. This Agreement shall be binding upon and inure to
the benefit of the parties hereto and their respective successors and permitted assigns. This Agreement shall create and constitute the continuing obligations of the parties hereto in accordance with its terms, and shall remain in full force and
effect until such time as the parties hereto shall agree. 
 Section 9.11 Cumulative Remedies. The remedies herein provided are
cumulative and not exclusive of any remedies provided by law. 
 Section 9.12 Nonpetition Covenant. Each party hereto agrees
that, prior to the date which is one year and one day after payment in full of all obligations of each Bankruptcy Remote Party in respect of all securities issued by any Bankruptcy Remote Party (i) such party hereto shall not authorize any
Bankruptcy Remote Party to commence a voluntary winding-up or other voluntary case or other Proceeding seeking liquidation, reorganization or other relief with respect to such Bankruptcy Remote Party or its
debts under any bankruptcy, insolvency or other similar law now or hereafter in effect in any jurisdiction or seeking the appointment of an administrator, a trustee, receiver, liquidator, custodian or other similar official with respect to such
Bankruptcy Remote Party or any substantial part of its property or to consent to any such relief or to the appointment of or taking possession by any such official in an involuntary case or other Proceeding commenced against such Bankruptcy Remote
Party, or to make a general assignment for the benefit of its creditors generally, any party hereto or any other creditor of such Bankruptcy Remote Party, and (ii) such party shall not commence, join with any other Person in commencing or
institute with any other Person, any Proceeding against such Bankruptcy Remote Party under any bankruptcy, reorganization, liquidation or insolvency law or statute now or hereafter in effect in any jurisdiction. This Section shall survive the
termination of this Agreement. 
 Section 9.13 Submission to Jurisdiction; Waiver of Jury Trial. Each of the parties hereto
hereby irrevocably and unconditionally: 
 (a) submits for itself and its property in any Proceeding relating to this Agreement or any
documents executed and delivered in connection herewith, or for recognition and enforcement of any judgment in respect thereof, to the nonexclusive general jurisdiction of the courts of the State of New York, the courts of the United States of
America for the Southern District of New York and appellate courts from any thereof; 
 (b) consents that any such Proceeding may be brought
and maintained in such courts and waives any objection that it may now or hereafter have to the venue of such Proceeding in any such court or that such Proceeding was brought in an inconvenient court and agrees not to plead or claim the same; 

(c) agrees that service of process in any such Proceeding may be effected by mailing a copy thereof by registered or certified mail (or any
substantially similar form of mail), postage prepaid, to such Person at its address determined in accordance with Section 9.02 of this Agreement; 

  

					
		  	20	  	 Asset Representations Review Agreement

(SDART 2021-2)

 (d) agrees that nothing herein shall affect the right to effect service of process in any
other manner permitted by law or shall limit the right to sue in any other jurisdiction; and 
 (e) to the extent permitted by applicable
law, each party hereto irrevocably waives all right of trial by jury in any Proceeding or counterclaim based on, or arising out of, under or in connection with this Agreement, any other Transaction Document, or any matter arising hereunder or
thereunder. 
 Section 9.14 Third-Party Beneficiaries. This Agreement shall inure to the benefit of and be binding upon the
parties hereto and their respective successors and permitted assigns and each of the Owner Trustee and the Indenture Trustee shall be an express third-party beneficiary hereof and may enforce the provisions hereof as if it were a party hereto.
Except as otherwise provided in this Section, no other Person will have any right hereunder. 
 [SIGNATURES ON NEXT PAGE] 

  

					
		  	21	  	 Asset Representations Review Agreement

(SDART 2021-2)

 IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the day and year
first written above. 
  

			
	SANTANDER CONSUMER USA INC.
		
	By:	 	 
		 	Name: Corey Henry
		 	Title: Vice President

  

			
	SANTANDER DRIVE AUTO RECEIVABLES TRUST 2021-2
		
	By:	 	Wilmington Trust, National Association, not in its individual capacity but solely as Owner Trustee

  

			
		
	By:	 	 
		 	Name:
		 	Title:

  

			
	 CLAYTON FIXED INCOME SERVICES LLC,

as Asset Representations Reviewer

		
	By:	 	 
		 	Name:
		 	Title:

  

					
		  	S-1	  	 Asset Representations Review Agreement

(SDART 2021-2)

 EXHIBIT A 
  

 
  
  

Santander Consumer USA Agreed Upon Procedures 
  

 Representation 
  

	 	a)	 Characteristics of Receivables 

As of the Cut-Off Date (or such other date as may be specifically set forth below), each Receivable: 

(i) has been fully and properly executed or electronically authenticated by the Obligor thereto; 

(ii) either (A) has been originated by a Dealer to finance the retail sale by that Dealer of the related Financed Vehicle and has been
purchased by Santander Consumer in accordance with the terms of a dealer agreement between Santander Consumer and that Dealer, (B) has been originated by Santander Consumer or (C) has been acquired by Santander Consumer in accordance with
the terms of a purchase agreement between the applicable originator and Santander Consumer; 
 (iii) as of the Closing Date, is secured by a
first priority validly perfected security interest in the Financed Vehicle in favor of the Originator, as secured party, or all necessary actions have been commenced that would result in a first priority security interest in the Financed Vehicle in
favor of the Originator, as secured party; 
 (iv) contains customary and enforceable provisions such that the rights and remedies of the
holder thereof are adequate for realization against the collateral of the benefits of the security; 
 (v) provided, at origination, for
level monthly payments which fully amortize the initial Principal Balance over the original term; provided, that the amount of the first or last scheduled payment may be different from the level payment but in no event more than three times the
level monthly payment; 
 (vi) provides for interest at the Contract Rate specified in the Schedule of Receivables; 

(vii) was originated in the United States and denominated in Dollars; 

(viii) is secured by a new or used automobile, light-duty truck, SUV or van; 

(ix) has a Contract Rate of at least 0.00%; 

  

					
		  	Exh. A - 1	  	 Asset Representations Review Agreement

(SDART 2021-2)

 

 
  
  

Santander Consumer USA Agreed Upon Procedures 
  

 (x) had an original term to maturity of not more than 75 months and each Receivable has a
remaining term to maturity, as of the Cut-Off Date, of not more than 75 months and not less than 4 months; 

(xi) has an outstanding Principal Balance of at least $500.00 and no more than $150,000.00; 

(xii) has a final scheduled payment due not later than August 9, 2027; 

(xiii) was not more than 30 days past due as of the Cut-Off Date; 

(xiv) was not identified in the records of the Servicer as being the subject of any pending bankruptcy or insolvency proceeding; 

(xv) is not subject to a force-placed Insurance Policy on the related Financed Vehicle; 

(xvi) is a Simple Interest Receivable; and 

(xvii) provides that a prepayment by the related Obligor will fully pay the Principal Balance and accrued interest through the date of
prepayment based on the Receivable’s Contract Rate. 
 Documents 

Retail Sale Contract 
 Title Documents 

Receivable File 
 Schedule of Receivables 

Servicing System/Data Tape 
 Procedures to be Performed

  

	i)	 Confirm the contract was signed or electronically authenticated by the obligor 

 

	ii)	 Origination of the Receivable 

a) Review the Retail Sale Contract and confirm that Santander Consumer USA or another Approved Party is listed as the Assignee within the
Assignment Section.1 
  

	iii)	 Security Interest Enforcement 

 

	1 	 “Approved Party” means a party specified as an “Approved Party” on the list of Approved
Parties provided by Santander Consumer to Clayton. 

  

					
		  	Exh. A - 2	  	 Asset Representations Review Agreement

(SDART 2021-2)

 

 
  
  

Santander Consumer USA Agreed Upon Procedures 
  

	 	a)	 Confirm the title documents show Santander Consumer USA or another Approved Party as the first lienholder

  

	 	b)	 Review the servicing system and confirm the Pool ID in the system matches the Pool ID for the transaction
related to the deal 

  

	iv)	 Customary and Enforceable Provisions 

 

	 	a)	 Confirm the Contract form number is listed on the Approved Contract Form List2 

  

	v)	 Fully Amortizing Payment Schedule 

 

	 	a)	 Confirm all payments are equivalent with the possible exception that the first and last payments may be
different from the level monthly payment 

  

	 	I)	 If the first and last payments are different from the level monthly payment, confirm that these payments are no
more than three times the level monthly payment amount 

  

	 	b)	 Review the Truth in Lending section of the Retail Sale Contract and calculate the product of the Amount of
Payments with the Number of Payments and confirm that this amount is equal to the Total of Payments 

  

	vi)	 Provides for Interest at the Contract Rate 

 

	 	a)	 Review the Schedule of Receivables and confirm that the stated rate is equal to the APR as shown in the Federal
Truth in Lending section of the Retail Sale Contract 

  

	vii)	 Origination of the Receivable 

 

	 	a)	 Review the Retail Sale Contract and confirm the Dealer address is in the United States 

 

	 	b)	 Review the Retail Sale Contract and confirm that the amounts stated within the Truth in Lending section are
denominated in US dollars 

  

	viii)	 Condition, Make and Model of Financed Vehicle 

 

	 	a)	 Review the New/Used section of the Retail Sale Contract and confirm that the Financed Vehicle is stated to be
new or used 

  

	 	b)	 Review the “Year and Make” and “Model” sections of the Retail Sale Contract and confirm
that the Financed Vehicle constitutes a light-duty truck or van 

  

	ix)	 Contract Annual Percentage Rate 

 

	 	a)	 Review the Federal Truth in Lending Section of the Retail Sale Contract and Confirm that the Annual Percentage
Rate is greater than the minimum allowed percentage rate 

  

	x)	 Remaining Maturity Date 

 

	 	a)	 Confirm that the Number of Payments section within the Truth in Lending section of the Retail Sale Contract
indicates a number of payments that does not exceed the maximum allowable number of payments 

  

	 	b)	 Review the Data Tape and confirm that the remaining term to maturity is within the stated allowable limits

  

	xi)	 Outstanding Principal Balance 

 

	2 	 “Approved Contract Form List” means a list of Approved Contract Forms provided by Santander Consumer
to Clayton. 

  

					
		  	Exh. A - 3	  	 Asset Representations Review Agreement

(SDART 2021-2)

 

 
  
  

Santander Consumer USA Agreed Upon Procedures 
  

	 	a)	 Review the Data and confirm that the Unpaid Principal Balance as of the Cutoff Date is within the stated
allowable limits 

  

	xii)	 Final Scheduled Payment Date 

 

	 	a)	 Review the Data Tape and confirm that the Final Scheduled Payment Due Date will occur on or before the latest
allowable final payment date 

  

	xiii)	 Days Past Due 

  

	 	a)	 Review the data file and confirm the Receivable was not more than 30 days past due as of the Cutoff Date

  

	xiv)	 Bankruptcy 

  

	 	a)	 Review the Receivable File and any applicable servicing notes and confirm there is no indication of pending
bankruptcy or insolvency proceedings 

  

	xv)	 Force Place Insurance 

 

	 	a)	 Review the servicing system and confirm the Receivable did not have Force Place Insurance as of the Cutoff Date

  

	xvi)	 Simple Interest Receivable 

 

	 	a)	 Confirm the Contract is a Simple Interest Contract 

 

	 	b)	 Review the payment history and confirm the first payment was appropriately applied to principal and interest

  

	xvii)	 Prepayment 

  

	 	a)	 Confirm the contract contains the appropriate Prepayment Disclosures 

 

	xviii)	 If sections i through xvii are confirmed, then Test Pass 

  

					
		  	Exh. A - 4	  	 Asset Representations Review Agreement

(SDART 2021-2)

 

 
  
  

Santander Consumer USA Agreed Upon Procedures 
  

 Representation 
  

	 	b)	 Compliance with Law 

The Receivable complied at the time it was originated or made in all material respects with all requirements of applicable federal, state and local laws, and
regulations thereunder, except where the failure to comply (i) was remediated or cured in all material respects prior to the Cut-Off Date or (ii) would not render such Receivable unenforceable or
create liability for the Purchaser or the Issuer, as assignee of such Receivable. 
 Document 

Retail Sale Contract 
 Servicing System/Data Tape 

Approved Contract Form List 
 Procedures to be Performed

  

	i)	 Confirm the Contract Form number and revision date are on the Approved Contract Form List

  

	ii)	 Confirm the Contract is complete 

 

	 	a)	 Confirm that all lines in the contract are filled out appropriately 

 

	 	b)	 Confirm the Name and address of Creditor, APR, Finance Charge, Amount of Payments, Total of Payments and Total
Sale Price are properly filled out 

  

	 	c)	 Confirm all lines on the contract are completed or properly left blank 

 

	iii)	 Confirm the Amount Financed is correctly calculated 

 

	 	a)	 Calculate the Amount Financed using the Cash Price, Total Down Payment and Total Amount Paid on Buyer’s
Behalf 

  

	 	b)	 Confirm the Calculated Amount Financed matches the Amount Financed as stated within the Truth in Lending
section of the Contract 

  

	iv)	 Confirm the Total Sale Price is correctly calculated 

 

	 	a)	 Calculate the Total Sale Price by taking the difference of the Total of Payments as stated within the Truth in
Lending section and the Total Down Payment as stated within the Itemization of Amount Financed 

  

	 	b)	 Confirm the Calculated Total Sale Price matches the Total Sale Price as stated within the Truth in Lending
section of the Contract 

  

	v)	 Confirm the Total of Payments is correctly calculated 

 

	 	a)	 Calculate the Total of Payments by taking the product of the Number of Payments and Amount of Payments as
stated within the Truth in Lending section of the Contract 

  

					
		  	Exh. A - 5	  	 Asset Representations Review Agreement

(SDART 2021-2)

 

 
  
  

Santander Consumer USA Agreed Upon Procedures 
  

	 	b)	 Confirm the Calculated Total of Payments from step (a) is equal to the Total of Payments as stated within
the Truth in Lending section of the Contract 

  

	 	c)	 Calculate the Total of Payment by taking the sum of the Finance Charge and Amount Financed as stated within the
Truth in Lending section of the Contract 

  

	 	d)	 Confirm the Calculated Total of Payments from step (c) is equal to the Total of Payments as stated within
the Truth in Lending section of the Contract 

  

	vi)	 Confirm the APR is correctly calculated 

 

	 	a)	 Calculate the APR using information within the Truth in Lending section of the Contract 

 

	 	b)	 Confirm the Calculated APR is within an acceptable range of the APR as stated within the Truth in Lending
Section of the Contract 

  

	vii)	 Confirm the first payment due date as stated within the When Payments are Due section of the Truth in Lending
section of the Contract is within an acceptable timeframe of the Contract Date 

  

	viii)	 If Steps i through vii are confirmed, then Test Pass 

  

					
		  	Exh. A - 6	  	 Asset Representations Review Agreement

(SDART 2021-2)

 

 
  
  

Santander Consumer USA Agreed Upon Procedures 
  

 Representation 
  

	 	c)	 Binding Obligation 

The Receivable constitutes the legal, valid and binding payment obligation in writing of the related Obligor, enforceable by the holder thereof in accordance
with its terms, except (i) as enforceability may be limited by applicable bankruptcy, insolvency, reorganization, liquidation or other similar laws and equitable principles relating to or affecting the enforcement of creditors’ rights
generally and (ii) as such Receivable may be modified by the application after the Cut-Off Date of the Servicemembers Civil Relief Act, as amended, to the extent applicable to the related Obligor. 

Documents 
 Retail Sale Contract 

Procedures to be Performed 
  

	i)	 Confirm the Contract Form number is on the Approved Contract Form List. 

 

	ii)	 Confirm the borrower and co-borrower (if applicable) signed the
contract 

  

	iii)	 If Steps i and ii are confirmed, then Test Pass 

  

					
		  	Exh. A - 7	  	 Asset Representations Review Agreement

(SDART 2021-2)

 

 
  
  

Santander Consumer USA Agreed Upon Procedures 
  

 Representation 
  

	 	d)	 Receivable in Force 

The Receivable has not been satisfied, subordinated or rescinded nor do the records of the Servicer indicate that the related Financed Vehicle has been
released from the lien of such Receivable in whole or in part. 
 Documents 

Servicing System/Data Tape 
 Title Documents 

Procedures to be Performed 
 i) Confirm the
Receivable exists on the Servicing System as an active Receivable 
 ii) Confirm the title documents show Santander Consumer USA or another Approved Party as
the first lienholder 
 iii) If Steps i and ii are confirmed, then Test Pass 

  

					
		  	Exh. A - 8	  	 Asset Representations Review Agreement

(SDART 2021-2)

 

 
  
  

Santander Consumer USA Agreed Upon Procedures 
  

 Representation 
  

	 	e)	 No Default; No Waiver 

Except for payment delinquencies continuing for a period of not more than 30 days as of the Cut-Off Date, the records
of the Servicer did not disclose that any default, breach, violation or event permitting acceleration under the terms of the Receivable existed as of the Cut-Off Date or that any continuing condition that with
notice or lapse of time, or both, would constitute a default, breach, violation or event permitting acceleration under the terms of the Receivable had arisen as of the Cut-Off Date and the Seller has not
waived any of the foregoing. 
 Documents 

Receivable File 
 Servicing System/Data Tape 

Procedures to be Performed 
  

	i)	 Confirm there is no indication of a default, breach, violation or event that would permit acceleration
under the terms of the Receivable except for payment default within 30 days of the Cut-Off Date 

  

	ii)	 Confirm that no continuing condition would constitute a default, breach, violation or event permitting
acceleration under the terms of the Receivable 

  

	iii)	 If Steps (i) and (ii) are confirmed, then Test Pass 

  

					
		  	Exh. A - 9	  	 Asset Representations Review Agreement

(SDART 2021-2)

 

 
  
  

Santander Consumer USA Agreed Upon Procedures 
  

 Representation 
  

	 	f)	 Insurance 

The Receivable requires that the Obligor thereunder obtain physical damage insurance covering the related Financed Vehicle. 

Documents 
 Retail Sale Contract 

Procedures to be Performed 
  

	i)	 Confirm the Retail Sale Contract contains language that required the Obligor to obtain and maintain insurance
against physical damage to the Financed Vehicle 

  

	ii)	 If confirmed, then Test Pass 

  

					
		  	Exh. A - 10	  	 Asset Representations Review Agreement

(SDART 2021-2)

 

 
  
  

Santander Consumer USA Agreed Upon Procedures 
  

 Representation 
  

	 	g)	 No Government Obligor 

The Obligor on the Receivable is not the United States or any state thereof or any local government, or any agency, department, political subdivision or
instrumentality of the United States or any state thereof or any local government. 
 Documents 

Retail Sale Contract 
 Procedures to be Performed

  

	i)	 Review the buyer section on the Contract and confirm a person’s or business name is reported

  

	ii)	 If the buyer section on the Contract does not report a person’s or business name, confirm internet
search results do not indicate the buyer to be a government agency, department, political subdivision or instrumentality. 

  

	iii)	 If (i) and (ii) are confirmed, then Test Pass 

  

					
		  	Exh. A - 11	  	 Asset Representations Review Agreement

(SDART 2021-2)

 

 
  
  

Santander Consumer USA Agreed Upon Procedures 
  

 Representation 
  

	 	h)	 Assignment 

No Receivable has been originated in, or is subject to the laws of, any jurisdiction under which the sale, transfer, assignment, contribution, conveyance or
pledge of such Receivable would be unlawful, void, or voidable. 
 Documents 

Retail Sale Contract 
 Receivable File 

Servicing System 
 Procedures to be Performed 

 

	i)	 Confirm the Retail Sale Contract was completed on a contract form included in the Approved Contract Form List

  

	ii)	 If Step (i) is confirmed, then Test Pass 

  

					
		  	Exh. A - 12	  	 Asset Representations Review Agreement

(SDART 2021-2)

 

 
  
  

Santander Consumer USA Agreed Upon Procedures 
  

 Representation 
  

	 	i)	 Good Title 

As of the Closing Date and immediately prior to the sale and transfer contemplated in the Purchase Agreement and the Sale and Servicing Agreement, Santander
Consumer had good and marketable title to and was the sole owner of each Receivable free and clear of all Liens created by Santander Consumer (except any Lien which will be released prior to assignment of such Receivable thereunder), and,
immediately upon the sale and transfer thereof, the Issuer will have good and marketable title to each Receivable, free and clear of all Liens created by Santander Consumer (other than Permitted Liens). 

Documents 
 Title Documents 

Procedures to be Performed 
  

	i)	 Confirm the title documents show Santander Consumer USA or another Approved Party as the first lienholder

  

	ii)	 Review the servicing system and confirm the Pool ID in the system matches the Pool ID for the transaction
related to the deal 

  

	iii)	 If (i) and (ii) are confirmed, then Test Pass 

  

					
		  	Exh. A - 13	  	 Asset Representations Review Agreement

(SDART 2021-2)

 

 
  
  

Santander Consumer USA Agreed Upon Procedures 
  

 Representation 
  

	 	j)	 Characterizations of Receivables 

Each Receivable constitutes either “tangible chattel paper”, “electronic chattel paper”, an “account”, an
“instrument”, or a “general intangible”, each as defined in the UCC. 
 Documents 

Contract 
 Title Documents 

Approved Contract Form List 
 Procedures to be Performed

  

	i)	 Confirm the Contract form number is on the Approved Contract Form List 

 

	ii)	 Confirm the Amount Financed as reported on the Contract is greater than zero 

 

	iii)	 Confirm there is documentation of a lien against the financed vehicle 

 

	iv)	 If tests (i) through (iii) are confirmed, then Test Pass 

  

					
		  	Exh. A - 14	  	 Asset Representations Review Agreement

(SDART 2021-2)

 

 
  
  

Santander Consumer USA Agreed Upon Procedures 
  

 Representation 
  

	 	k)	 One Original 

There is only one executed original, electronically authenticated original or authoritative copy of the Contract (in each case within the meaning of the UCC)
related to each Receivable. 
 Documents 

Contract 
 Procedures to be Performed 

 

	i)	 Confirm there is a final version of the Contract available for review 

 

	ii)	 Confirm the Contract was signed by the buyer(s) and the Dealer 

 

	iii)	 If (i) and (ii) are confirmed, then Test Pass 

  

					
		  	Exh. A - 15	  	 Asset Representations Review Agreement

(SDART 2021-2)

 

 
  
  

Santander Consumer USA Agreed Upon Procedures 
  

 Representation 
  

	 	l)	 No Defenses 

The records of the Servicer do not reflect any material facts which have not been remediated or cured which would constitute the basis for any right of
rescission, offset, claim, counterclaim or defense with respect to such Receivable or the same being asserted or threatened with respect to such Receivable. 

Documents 
 Receivable File 

Procedures to be Performed 
  

	i)	 Review the Receivable File and servicing system and confirm there is no evidence of litigation or other
attorney involvement as of the Cut-Off Date. 

  

	ii)	 If confirmed, then Test Pass. 

  

					
		  	Exh. A - 16	  	 Asset Representations Review Agreement

(SDART 2021-2)

 

 
  
  

Santander Consumer USA Agreed Upon Procedures 
  

 Representation 
  

	 	m)	 Early Payments 

The Obligor on the Receivable has made, or will make, the first two monthly payments under such Receivable. 

Documents 
 Servicing System/Data Tape 

Procedures to be Performed 
  

	i)	 Confirm that there is no indication that the Obligor did not make the first two monthly payments on the
Receivable by verifying that the payments made field in the Data Tape is at least two as of the Review Date. 

  

	ii)	 If Step i is confirmed, then Test Pass. 

  

					
		  	Exh. A - 17	  	 Asset Representations Review Agreement

(SDART 2021-2)Exhibit 10.1

 

Harvard Bioscience, Inc.

 

2021 Incentive Plan

 

Article 1

Establishment and Purpose

 

1.1               
Establishment of the Plan. Harvard Bioscience, Inc., a Delaware corporation (the “Company”), hereby
establishes an incentive compensation plan (as amended from time to time, the “Plan”), as set forth in this
document.

 

1.2               
Purpose of the Plan. The purposes of the Plan are to (a) enable the Company and any Affiliate to attract and retain
the types of Employees, Consultants and Directors who will contribute to the Company’s long-range success; (b) provide incentives
that align the interests of Employees, Consultants and Directors with those of shareholders of the Company; and (c) promote the
success of the Company’s business.

 

1.3               
Effective Date of the Plan. The Plan is effective as of the date the Plan is approved by the Company’s stockholders
(the “Effective Date”). The Plan will be deemed to be approved by the stockholders if it receives the affirmative
vote of the holders of a majority of the shares of stock of the Company present or represented and entitled to vote at a meeting
duly held in accordance with the applicable provisions of the Company’s Bylaws.

 

1.4               
Duration of the Plan. Unless sooner terminated as provided herein, the Plan shall terminate ten (10) years from the
Effective Date. After the Plan is terminated, no Awards may be granted but Awards previously granted shall remain outstanding in
accordance with their applicable terms and conditions and the Plan’s terms and conditions.

 

Article 2

Definitions

 

Whenever used in the Plan, the following terms
shall have the meanings set forth below and, when the meaning is intended, the initial letter of the word is capitalized:

 

2.1               
“Affiliate” means, with respect to any Person, any other Person that directly or indirectly through one
or more intermediaries controls, is controlled by or is under common control with, the Person in question, including any subsidiary.
As used herein, the term “control” means the possession, direct or indirect, of the power to direct or cause the direction
of the management and policies of a Person, whether through ownership of voting securities, by contract or otherwise. As used herein,
the term “subsidiary” means any corporation, partnership, venture or other entity in which the Company holds, directly
or indirectly, a fifty percent (50%) or greater ownership interest.

 

2.2               
“Applicable Law” means any applicable law, including without limitation: (a) provisions of the Code,
the Securities Act, the Exchange Act and any rules or regulations thereunder; (b) corporate, securities, tax or other laws, statutes,
rules, requirements or regulations, whether federal, state, local or foreign; and (c) rules of any securities exchange or automated
quotation system on which the Shares are listed, quoted or traded.

 

2.3               
“Award” means, individually or collectively, a grant or award under this Plan of Options, Stock Appreciation
Rights, Restricted Stock (including unrestricted Stock), Restricted Stock Units, Performance Stock Units, Performance Shares, Deferred
Stock Awards, Other Stock-Based Awards, Dividend Equivalent Awards and Performance Bonus Awards, in each case subject to the terms
of the Plan.

 

2.4               
“Award Agreement” means an agreement, certificate, resolution or other type or form of writing or other
evidence approved by the Committee which sets forth the terms and conditions of an Award. An Award Agreement may be in any electronic
medium, may be limited to a notation on the books and records of the Company and, with the approval of the Committee, need not
be signed by a representative of the Company or a Participant. In the event of any inconsistency between the Plan and an Award
Agreement, the terms of the Plan shall govern.

 

2.5               
“Beneficial Owner” or “Beneficial Ownership” has the meaning ascribed to such term
in Rule 13d-3 and Rule 13d-5 under the Exchange Act.

 

2.6               
“Board” or “Board of Directors” means the Company’s Board of Directors.

 

     

     

    

 

2.7               
“Cause” means, except as otherwise defined in an Award Agreement, a Participant’s: (a) conviction
of, or the entry of a plea of guilty or no contest to, a felony or any other crime that causes the Company or its Affiliates public
disgrace or disrepute, or materially and adversely affects the Company’s or its Affiliates’ operations or financial
performance or the relationship the Company has with its customers; (b) gross negligence or willful misconduct with respect to
the Company or any of its Affiliates, including, without limitation fraud, embezzlement, theft or proven dishonesty in the course
of his or her employment or other service; (c) refusal to perform any lawful, material obligation or fulfill any duty (other than
any duty or obligation of the type described in clause (e) below) to the Company or its Affiliates (other than due to a Disability),
which refusal, if curable, is not cured within fifteen (15) days after delivery of written notice thereof; (d) material breach
of any agreement with or duty owed to the Company or any of its Affiliates, which breach, if curable, is not cured within fifteen
(15) days after the delivery of written notice thereof; or (e) any breach of any obligation or duty to the Company or any of its
Affiliates (whether arising by statute, common law or agreement) relating to confidentiality, noncompetition, nonsolicitation or
proprietary rights. Notwithstanding the foregoing, if a Participant and the Company (or any of its Affiliates) have entered into
an employment agreement, consulting agreement or other similar agreement that specifically defines “cause,” then with
respect to such Participant, “Cause” shall have the meaning defined in that employment agreement, consulting agreement
or other agreement.

 

2.8               
“Change in Control” shall be deemed to have occurred if:

 

(a)                
any Person, other than a trustee or other fiduciary holding securities under an employee benefit plan of the Company or
a corporation owned directly or indirectly by the stockholders of the Company in substantially the same proportions as their ownership
of stock of the Company, becomes the Beneficial Owner, directly or indirectly, of securities of the Company representing fifty
percent (50%) or more of the total voting power represented by the Company’s then outstanding voting securities;

 

(b)               
during any period of two (2) consecutive years, individuals who at the beginning of such period constitute the Board of
Directors of the Company and any new Director whose election by the Board of Directors or nomination for election by the Company’s
stockholders was approved by a vote of a majority of the Directors then still in office who either were Directors at the beginning
of the period or whose election or nomination for election was previously so approved, cease for any reason to constitute a majority
thereof, provided that this does not apply to a Director whose initial assumption of office during the lookback period is in connection
with an actual or threatened election contest, including but not limited to a consent solicitation, relating to the election of
Directors of the Company;

 

(c)                
the consummation of a merger or consolidation of the Company with any other business entity, other than a merger or consolidation
which would result in the voting securities of the Company outstanding immediately prior thereto continuing to represent (either
by remaining outstanding or by being converted into voting securities of the surviving entity) at least fifty percent (50%) of
the total voting power represented by the voting securities of the Company or such surviving entity outstanding immediately after
such merger or consolidation;

 

(d)               
the stockholders of the Company approve a plan of complete liquidation of the Company or an agreement for the sale or disposition
by the Company of all or substantially all the Company’s assets; or

 

(e)                
consummation of the sale or disposition by the Company of all or substantially all of the Company’s assets.

 

Notwithstanding the foregoing, if a Change in
Control constitutes a payment event with respect to any Award (or any portion of an Award) that provides for the deferral of compensation
that is subject to Section 409A of the Code, to the extent required to avoid the imposition of additional taxes under Section 409A
of the Code, the transaction or event described in subsection (a), (b), (c) or (d) with respect to such Award (or portion thereof)
shall only constitute a Change in Control for purposes of the payment timing of such Award if such transaction also constitutes
a “change in control event,” as defined in Treasury Regulation Section 1.409A-3(i)(5).

 

The Committee shall have full and final authority,
which shall be exercised in its sole discretion, to determine conclusively whether a Change in Control has occurred pursuant to
the above definition, the date of the occurrence of such Change in Control and any incidental matters relating thereto; provided
that any exercise of authority in conjunction with a determination of whether a Change in Control is a “change in control
event” as defined in Treasury Regulation Section 1.409A-3(i)(5) shall be consistent with such regulation.

 

2.9               
“Code” means the Internal Revenue Code of 1986, as amended from time to time, and the Treasury Regulations
issued thereunder.

 

    2

     

    

 

2.10            
“Committee” has the meaning set forth in Section 3.1.

 

2.11            
“Company” has the meaning set forth in Section 1.1.

 

2.12            
“Consultant” means any individual or entity who renders bona fide services to the Company or an Affiliate,
other than as an Employee or Director, provided that such services are not in connection with the offer or sale of securities
in a capital-raising transaction and do not, directly or indirectly, promote or maintain a market for the Company’s or its
Affiliates’ securities.

 

2.13            
“Deferred Stock” means a right to receive a specified number of shares of Stock during specified time
periods pursuant to Article 9.

 

2.14            
“Director” means a member of the Board.

 

2.15            
“Disability” means, unless otherwise determined by the Committee or determined in the applicable Award
Agreement, that the Participant is unable to engage in any substantial gainful activity by reason of any medically determinable
physical or mental impairment; provided, however, that to entitle a Participant to an extended exercise period for an Incentive
Stock Option, the Participant must be described in Section 22(e)(3) of the Code. Notwithstanding the foregoing, for Awards subject
to Section 409A of the Code, Disability shall mean that a Participant is disabled under Section 409A(a)(2)(C)(i) or (ii) of the
Code. Notwithstanding the above, the Committee may rely on any determination that a Participant is disabled for purposes of benefits
under any long-term disability plan maintained by the Company or any Affiliate in which a Participant participates.

 

2.16            
“Dividend Equivalent” means a right granted to a Participant pursuant to Article 9 to receive
the equivalent value (in cash or Stock) of dividends paid on Stock.

 

2.17            
“Effective Date” has the meaning set forth in Section 1.3.

 

2.18            
“Eligible Person” means any person who is an employee, officer, director, consultant, advisor or other
individual service provider of the Company or any Affiliate, or any person who is determined by the Committee to be a prospective
employee, officer, director, consultant, advisor or other individual service provider of the Company or any Affiliate.

 

2.19            
 “Employee” means any person employed by the Company, its Affiliates and/or Subsidiaries; provided,
that, for purposes of determining eligibility to receive Incentive Stock Options, an Employee shall mean an employee of
the Company or a parent or subsidiary corporation within the meaning of Section 424 of the Code. Mere service as a Director or
payment of a director’s fee by the Company or an Affiliate shall not be sufficient to constitute “employment”
by the Company or an Affiliate.

 

2.20            
“Exchange Act” means the Securities Exchange Act of 1934, as amended from time to time, or any successor
act thereto.

 

2.21            
“Exercise Price” means the price at which a Share may be purchased by a Participant pursuant to an Option,
as determined by the Committee.

 

2.22            
“Fair Market Value” or “FMV” means, as of any date, unless otherwise determined by
the Committee or determined in an applicable Award Agreement, the value of Stock determined as follows:

 

(a)                
If the Stock is listed on one or more established stock exchanges or national market systems, including without limitation,
The NASDAQ Global Select Market, The NASDAQ Global Market or The NASDAQ Capital Market of The NASDAQ Stock Market LLC, its Fair
Market Value shall be the closing sales price for such Stock (or the closing bid, if no sales were reported) as quoted on the principal
exchange or system on which the Stock is listed (as determined by the Committee) on the date of determination (or, if no closing
sales price or closing bid was reported on that date, as applicable, on the last immediately preceding trading date such closing
sales price or closing bid was reported), as reported in The Wall Street Journal or such other source as the Committee deems
reliable;

 

(b)               
If the Stock is regularly quoted on an automated quotation system (including the OTC Bulletin Board) or by a recognized
securities dealer, its Fair Market Value shall be the closing sales price for such Stock as quoted on such system or by such securities
dealer on the date of determination, but if selling prices are not reported, the Fair Market Value of a share of Stock shall be
the mean between the high bid and low asked prices for the Stock on the date of determination (or, if no such prices were reported
on that date, on the last date such prices were reported), as reported in The Wall Street Journal or such other source as
the Committee deems reliable; or

 

    3

     

    

 

(c)                
In the absence of an established market for the Stock of the type described in (a) and (b), above, the Fair Market Value
thereof shall be determined by the Committee in good faith using any reasonable method of valuation, which method may be set forth
with greater specificity in the Award Agreement, (and, to the extent necessary or advisable, in a manner consistent with Section
409A of the Code and Section 422 of the Code for Incentive Stock Options), which determination shall be conclusive and binding
on all interested parties. Such reasonable method may be determined by reference to (i) the placing price of the latest private
placement of the Shares and the development of the Company’s business operations and the general economic and market conditions
since such latest private placement; (ii) other third party transactions involving the Shares and the development of the Company’s
business operation and the general economic and market conditions since such sale; (iii) an independent valuation of the Shares
(by a qualified valuation expert); or (iv) such other methodologies or information as the Committee determines to be indicative
of Fair Market Value.

 

2.23            
“Incentive Stock Option” means an Option that is intended to qualify as an “incentive stock option”
within the meaning of Section 422 of the Code and that meets the requirements set out in the Plan.

 

2.24            
“Insider” means an individual who is, on the relevant date, an officer, director, or ten percent (10%)
beneficial owner of the Company, as those terms are defined under Section 16 of the Exchange Act, who is required to file reports
pursuant to Rule 16a-3 under the Exchange Act.

 

2.25            
“Non-Employee Director” means a member of the Board who is not an Employee of the Company.

 

2.26            
“Non-Qualified Stock Option” means an Option that, by its terms, does not qualify or is not intended
to qualify as an Incentive Stock Option.

 

2.27            
“Option” means the right to purchase Stock granted to a Participant in accordance with Article 6.
Options granted under the Plan may be Non-Qualified Stock Options, Incentive Stock Options or a combination thereof.

 

2.28            
“Other Stock-Based Award” means an equity-based or equity-related Award not otherwise described by the
terms of the Plan, granted pursuant to Article 9.

 

2.29            
“Participant” means an Eligible Person to whom an Award is granted under the Plan or, if applicable,
such other person who holds an outstanding Award.

 

2.30            
“Performance Goal” means any goals established by the Committee pursuant to an Award, which may be based
on the attainment of specified levels of one or more of the following: (i) earnings per share; (ii) sales; (iii) operating income;
(iv) gross income; (v) basic or adjusted net income (before or after taxes); (vi) cash flow; (vii) gross profit; (viii) gross or
operating margin; (ix) working capital; (x) earnings before interest and taxes; (xi) earnings before interest, tax, depreciation
and amortization; (xii) return measures, including return on invested capital, sales, assets, or equity; (xiii) revenues; (xiv)
market share; (xv) the price or increase in price of Stock; (xvi) total shareholder return; (xvii) economic value created or added;
(xviii) expense reduction; (xix) implementation or completion of critical projects, including acquisitions, divestitures, and other
strategic objectives, including market penetration and product development; (xx) specified objectives with regard to limiting the
level of increase in all or a portion of the Company's bank debt or other long-term or short-term public or private debt or other
similar financial obligations of the Company; or (xxi) any other metric that may be determined by the Committee. Such performance
goals also may be based solely by reference to the Company’s performance or the performance of a Subsidiary, division, business
segment or business unit of the Company or a Subsidiary, or based upon performance relative to performance of other companies or
upon comparisons of any of the indicators of performance relative to performance of other companies. The Committee may provide
for exclusion of the impact of an event or occurrence which the Committee determines should appropriately be excluded, including
(a) restructurings, discontinued operations, extraordinary items, and other unusual, infrequently occurring or non-recurring charges
or events, (b) asset write-downs, (c) litigation or claim judgments or settlements, (d) acquisitions or divestitures, (e) reorganization
or change in the corporate structure or capital structure of the Company, (f) an event either not directly related to the operations
of the Company, Subsidiary, division, business segment or business unit or not within the reasonable control of management, (g)
foreign exchange gains and losses, (h) a change in the fiscal year of the Company, (i) the refinancing or repurchase of bank loans
or debt securities, (j), unbudgeted capital expenditures, (k) the issuance or repurchase of equity securities and other changes
in the number of outstanding shares, (l) conversion of some or all of convertible securities to common stock, (m) any business
interruption event (n) the cumulative effects of tax or accounting changes in accordance with U.S. generally accepted accounting
principles, or (o) the effect of changes in other laws or regulatory rules affecting reported results. The Committee may adjust
upwards or downwards the amount payable pursuant to such performance-based Award, and the Committee shall certify the amount of
any such Award for the applicable performance period before payment is made.

 

    4

     

    

 

2.31            
“Performance Period” means one or more periods of time, which may be of varying and overlapping durations,
as the Committee may select, over which the attainment of one or more Performance Goals will be measured for the purpose of determining
a Participant’s right to, and the payment of, Performance Stock Units and Performance Shares.

 

2.32            
“Performance Stock Unit” and “Performance Share” each mean an Award granted to an
Employee pursuant to Article 9 herein.

 

2.33            
“Permitted Transferee” shall mean, with respect to a Participant, any “family member” of
the Participant, as defined in the General Instructions to Form S-8 Registration Statement under the Securities Act (or any successor
form thereto), or to any other transferee specifically approved by the Committee after taking into account Applicable Law, but
excluding any third-party financial institutions.

 

2.34            
“Person” has the meaning ascribed to such term in Section 3(a)(9) of the Exchange Act and used in Sections
13(d) and 14(d) thereof, including a “group” as defined in Section 13(d) thereof.

 

2.35            
“Plan” means this Harvard Bioscience, Inc. 2021 Incentive Plan, as it may be amended from time to time.

 

2.36            
“Prior Plan” means the 2000 Stock Option and Incentive Plan.

 

2.37            
“Restricted Stock” means Stock awarded to a Participant pursuant to Article 8 as to which the
Restriction Period has not lapsed.

 

2.38            
“Restricted Stock Unit” means an Award granted pursuant to Section 8.9 as to which the Restriction
Period has not lapsed.

 

2.39            
“Restriction Period” means the period when Restricted Stock or Restricted Stock Units are subject to
a “substantial risk of forfeiture” within the meaning of Section 83 of the Code (based on the passage of time, the
achievement of performance goals, or upon the occurrence of other events as determined by the Committee, in its discretion), as
provided in Article 8.

 

2.40            
“Securities Act” means the Securities Act of 1933, as amended.

 

2.41            
“Share” means a share of Stock of the Company.

 

2.42            
“Stock” means the common stock of the Company, par value $0.01 per share.

 

2.43            
“Stock Appreciation Right” or “SAR” means a right granted pursuant to Article 7
to receive an amount payable in cash or Shares equal to the excess of (a) the Fair Market Value of a specified number of Shares
on the date the SAR is exercised over (b) the Fair Market Value of such Shares on the date the SAR was granted as set forth in
the applicable Award Agreement.

 

2.44            
“Subsidiary” means any corporation, partnership, venture, unincorporated association or other entity
in which the Company holds, directly or indirectly, a fifty percent (50%) or greater ownership interest, provided, however, that
with respect to an Incentive Stock Option, a Subsidiary must be a corporation. The Committee may, at its sole discretion, designate,
on such terms and conditions as the Committee shall determine, any other corporation, partnership, limited liability company, venture,
or other entity a Subsidiary for purposes of this Plan.

 

2.45            
“Ten Percent Owner” means a person who owns, or is deemed within the meaning of Section 424(d) of
the Code to own, stock possessing more than 10% of the total combined voting power of all classes of stock of the Company (or any
parent or subsidiary corporations of the Company, as defined in Sections 424(e) and (f), respectively, of the Code). Whether
a person is a Ten Percent Owner shall be determined with respect to an Option based on the facts existing immediately prior to
the grant date of the Option.

 

2.46            
“Termination of Employment” or a similar reference means the event where the Employee is no longer an
Employee of the Company or of any Subsidiary, including but not limited to where the employing company ceases to be a Subsidiary.
With respect to any Participant who is not an Employee, “Termination of Employment” shall mean cessation of the performance
of services. With respect to any Award that provides “non-qualified deferred compensation” within the meaning of Section
409A of the Code, “Termination of Employment” shall mean a “separation from service” as defined under Section
409A of the Code. Military or sick leave or other bona fide leave shall not be deemed a termination of employment, provided that
it does not exceed the longer of three (3) months or the period during which the absent Participant’s reemployment rights,
if any, are guaranteed by statute or by contract.

 

    5

     

    

 

2.47            
“Treasury Regulation” or “Treas. Reg.” means any regulation promulgated under the
Code, as such regulation may be amended from to time.

 

Article 3

Administration

 

3.1               
The Committee. Except as otherwise provided herein, the Plan shall be administered by the Compensation Committee
of the Board (the “Committee”). Unless otherwise determined by the Board, the Committee shall consist solely
of two or more members of the Board each of whom is (a) a “non-employee director” within the meaning of Rule 16b-3
of the Exchange Act, and (b) an “independent director” under the rules of the Nasdaq Capital Market (or any similar
rule or listing requirement that may be applicable to the Company from time to time); provided, that any action taken by the Committee
shall be valid and effective, whether or not members of the Committee at the time of such action are later determined not to have
satisfied the requirements for membership set forth in this Section 3.1 or otherwise provided in any charter of the Committee.
Notwithstanding the foregoing: (a) the full Board, acting by a majority of its members in office or by designation to a Committee,
shall conduct the general administration of the Plan with respect to all Awards granted to Non-Employee Directors and for purposes
of such Awards the term “Committee” as used in this Plan shall be deemed to refer to the Board and (b) the Committee
may delegate its authority hereunder to the extent permitted by Section 3.4. In its sole discretion, the Board may at any
time and from time to time exercise any and all rights and duties of the Committee under the Plan except with respect to matters
which under Rule 16b-3 under the Exchange Act, or any regulations or rules issued thereunder, are required to be determined in
the sole discretion of the Committee. Except as may otherwise be provided in any charter of the Committee, appointment of Committee
members shall be effective upon acceptance of appointment; Committee members may resign at any time by delivering written notice
to the Board; and vacancies in the Committee may only be filled by the Board.

 

3.2               
Authority of the Committee. Subject to the general purposes, terms and conditions of this Plan and Applicable Law,
and to the direction of the Board, the Committee shall have complete control over the administration of the Plan and shall have
full authority to (a) exercise all of the powers granted to it under the Plan, (b) construe, interpret and implement the Plan,
grant terms and grant notices, and all Award Agreements, (c) prescribe, amend and rescind rules and regulations relating to the
Plan, including rules governing its own operations, (d) make all determinations necessary or advisable in administering the Plan,
(e) correct any defect, supply any omission and reconcile any inconsistency in the Plan, (f) amend the Plan to reflect changes
in applicable law (whether or not the rights of the holder of any Award are adversely affected, unless otherwise provided by the
Committee), (g) grant Awards and determine who shall receive Awards, when such Awards shall be granted and the terms and conditions
of such Awards, including, but not limited to, conditioning the exercise, vesting, payout or other term of condition of an Award
on the achievement of Performance Goals, (h) unless otherwise provided by the Committee, amend any outstanding Award in any respect,
not materially adverse to the Participant, including, without limitation, to (i) accelerate the time or times at which the Award
becomes vested, unrestricted or may be exercised (and, in connection with such acceleration, the Committee may provide that any
Shares acquired pursuant to such Award shall be restricted Shares, which are subject to vesting, transfer, forfeiture or repayment
provisions similar to those in the Participant’s underlying Award), provided, however, that any accelerated vesting is subject
to stockholder approval, (ii) accelerate the time or times at which Shares are delivered under the Award (and, without limitation
on the Committee’s rights, in connection with such acceleration, the Committee may provide that any shares of Stock delivered
pursuant to such Award shall be Restricted Shares, which are subject to vesting, transfer, forfeiture or repayment provisions similar
to those in the Participant’s underlying Award), or (iii) waive or amend any goals, restrictions or conditions applicable
to such Award, or impose new goals, restrictions and (i) determine at any time whether, to what extent and under what circumstances
and method or methods (i) Awards may be (A) settled in cash, Shares, other securities, other Awards or other property (in which
event, the Committee may specify what other effects such settlement will have on the Participant’s Award), (B) exercised
or (C) canceled, forfeited or suspended, (ii) Shares, other securities, cash, other Awards or other property and other amounts
payable with respect to an Award may be deferred either automatically or at the election of the Participant or of the Committee,
or (iii) Awards may be settled by the Company or any of its Subsidiaries or any of its or their designees.

 

No Award may be made under the Plan after the
tenth (10th) anniversary of the Effective Date.

 

3.3               
Committee Decisions Final. The act or determination of a majority of the Committee shall be the act or determination
of the Committee and any decision reduced to writing and signed by all of the members of the Committee shall be fully effective
as if it had been made by a majority at a meeting duly held. The Committee may employ attorneys, consultants, accountants, agents,
and other persons, any of whom may be an Employee, and the Committee, the Company, and its officers and Directors shall be entitled
to rely upon the advice, opinions, or valuations of any such persons. All actions taken and all interpretations and determinations
made by the Committee pursuant to the provisions of the Plan and all related orders or resolutions shall be final and binding upon
the Participants, the Company, and all other interested persons, including but not limited to the Company, its stockholders, Employees,
Participants, and their estates and beneficiaries.

 

    6

     

    

 

3.4               
Delegation of Authority. The Board or Committee may from time to time delegate to a committee of one or more members
of the Board or one or more officers of the Company the authority to grant or amend Awards or to take other administrative actions
pursuant to this Article 3; provided, however, that in no event shall an officer of the Company be delegated the authority
to grant Awards to, or amend Awards held by, the following individuals: (a) individuals who are subject to Section 16 of the Exchange
Act, or (b) officers of the Company (or Directors) to whom authority to grant or amend Awards has been delegated hereunder; provided,
further, that any delegation of administrative authority shall only be permitted to the extent it is permissible under the Company’s
Certificate of Incorporation, Bylaws and Applicable Law. Any delegation hereunder shall be subject to the restrictions and limits
that the Board or Committee specifies at the time of such delegation or that are otherwise included in the applicable Organizational
Documents, and the Board or Committee, as applicable, may at any time rescind the authority so delegated or appoint a new delegatee.
At all times, the delegatee appointed under this Section 3.4 shall serve in such capacity at the pleasure of the Board or
the Committee, as applicable, and the Board or the Committee may abolish any committee at any time and re-vest in itself any previously
delegated authority

 

3.5               
Indemnification. To the extent allowable pursuant to applicable law, each member of the Committee or of the Board
shall be indemnified and held harmless by the Company from any loss, cost, liability, or expense that may be imposed upon or reasonably
incurred by such member in connection with or resulting from any claim, action, suit, or proceeding to which he or she may be a
party or in which he or she may be involved by reason of any action or failure to act pursuant to the Plan and against and from
any and all amounts paid by him or her in satisfaction of judgment in such action, suit, or proceeding against him or her; provided
he or she gives the Company an opportunity, at its own expense, to handle and defend the same before he or she undertakes to handle
and defend it on his or her own behalf. The foregoing right of indemnification shall not be exclusive of any other rights of indemnification
to which such persons may be entitled pursuant to the Company’s Certificate of Incorporation or Bylaws, as a matter of law,
or otherwise, or any power that the Company may have to indemnify them or hold them harmless.

 

Article 4

Shares Subject to the Plan

 

4.1               
Number of Shares. Subject to adjustment as provided in Sections 4.2 and 4.3, the aggregate number of
Shares of Stock which may be issued or transferred pursuant to Awards under the Plan shall be the sum of 2,200,000 shares plus
the number of shares available for grant under the Prior Plan as of the Effective Date. Notwithstanding the foregoing, in order
that the applicable regulations under the Code relating to Incentive Stock Options be satisfied, the maximum number of shares of
Stock that may be delivered upon exercise of Incentive Stock Options shall be 2,000,000, as adjusted under Sections 4.2
and 4.3. Shares of Stock issued pursuant to the Plan may be either authorized but unissued Shares or Shares held by the
Company in its treasury. Upon effectiveness of the Plan, no further awards shall be granted under a Prior Plan.

 

4.2               
Share Accounting. Without limiting the discretion of the Committee under this section, the following rules will apply
for purposes of the determination of the number of Shares available for grant under the Plan or compliance with the foregoing limits:

 

(a)                
If an outstanding Award for any reason expires or is terminated or canceled without having been exercised or settled in
full, or if Shares acquired pursuant to an Award subject to forfeiture are forfeited under the terms of the Plan or the relevant
Award, the Shares allocable to the terminated portion of such Award or such forfeited Shares shall again be available for issuance
under the Plan. This subsection 4.2(a) shall also apply to awards granted under the Prior Plan, which are outstanding as
of the Effective Date.

 

(b)               
Shares shall not be deemed to have been issued pursuant to the Plan (or the Prior Plan) with respect to any portion of an
Award that is settled in cash, other than an Option.

 

(c)                
In the event that withholding tax liabilities arising from a full-value Award (i.e., an award other than an Option or SAR)
or, after the Effective Date, arising from a full-value award under the Prior Plan, are satisfied by the delivery or withholding
of shares, the shares so tendered or withheld shall be added to the 2021 Incentive Plan’s reserve. Notwithstanding anything
to the contrary contained herein, shares subject to an Award shall not again be made available for issuance or delivery under the
Plan if such shares are (i) shares tendered in payment of an Option; (ii) shares delivered or withheld by the Company to satisfy
any tax withholding obligation with respect to an Option or SAR; (iii) shares covered by a stock-settled Stock Appreciation Right
that were not issued upon the settlement of the SAR; or (iv) shares purchased on the open market with Option proceeds.

 

    7

     

    

 

4.3               
Adjustments in Authorized Plan Shares and Outstanding Awards. In the event of any merger, reorganization, consolidation,
recapitalization, separation, split-up, spin-off, liquidation, Share combination, Stock split, Stock dividend, an extraordinary
cash distribution on Stock, a corporate separation or other reorganization or liquidation or other change in the corporate or capital
structure of the Company affecting the Shares, an adjustment shall be made in a manner consistent with Sections 422 and 424(h)(3)
of the Code for Incentive Stock Options and in a manner consistent with Section 409A of the Code for Non-Qualified Stock Options
and Stock Appreciation Rights and in the number and class of and/or price of Shares subject to outstanding Awards granted under
the Plan, and/or the number of outstanding Options, Stock Appreciation Rights, Shares of Restricted Stock, and Performance Shares
(and Restricted Stock Units, Performance Stock Units and other Awards whose value is based on a number of Shares) constituting
outstanding Awards, as may be determined to be appropriate and equitable by the Committee, in its sole discretion, to prevent dilution
or enlargement of rights. The Committee shall also adjust any available share reserve accordingly. The Committee may make adjustments
in the terms and conditions of, and the criteria included in Awards in recognition of unusual or nonrecurring events (including,
without limitation, the events described in this Section) affecting the Company or the financial statements of the Company or of
changes in applicable laws, regulations, or accounting principles, whenever the Committee determines that such adjustments are
appropriate in order to prevent dilution or enlargement of the benefits or potential benefits intended to be made available under
the Plan. Adjustments under this Section 4.3 shall be consistent with Section 409A of the Code and adjustments pursuant
to determination of the Committee shall be conclusive and binding on all Participants under the Plan.

 

4.4               
Limitation on Number of Shares Granted to Non-Employee Directors. The maximum number of Shares subject to Awards
granted during a single fiscal year to any Non-Employee Director, taken together with any cash fees paid during the fiscal year
to the Non-Employee Director, in respect of such Director’s service as a member of the Board during such year (including
service as a member or chair of any committees of the Board), shall not exceed $500,000 in total value (calculating the value of
any such Awards based on the grant date Fair Market Value of such Awards for financial reporting purposes). The independent members
of the Board may make exceptions to this limit for a non-executive chair of the Board, provided that the Non-Employee Director
receiving such additional compensation may not participate in the decision to award such compensation.

 

Article 5

Eligibility and Participation

 

5.1               
Eligibility and Participation. Subject to the provisions of the Plan, the Committee may, from time to time, select
from all Eligible Persons, those to whom Awards shall be granted and shall determine, in its sole discretion, the nature of, any
and all terms permissible by law, and the amount of each Award. In making this determination, the Committee may consider any factors
it deems relevant, including without limitation, the office or position held by a Participant or the Participant’s relationship
to the Company, the Participant’s degree of responsibility for and contribution to the growth and success of the Company
or any Subsidiary or Affiliate, the Participant’s length of service, promotions and potential. No individual shall have the
right to be selected to receive an Award under this Plan, or, having been so selected, to be selected to receive a future Award.
In addition, there is no obligation for uniformity of treatment of Participants or holders or beneficiaries of Awards. The terms
and conditions of Awards and the Committee’s determinations and interpretations with respect thereto need not be the same
with respect to each Participant and may be made selectively among Participants, whether or not such Participants are similarly
situated.

 

5.2               
Foreign Participants. In order to assure the viability of Awards granted to Participants employed in foreign countries,
the Committee may provide for such special terms as it may consider necessary or appropriate to accommodate differences in local
law, tax policy, or custom. Moreover, the Committee may approve such supplements to, or amendments, restatements, or alternative
versions of, the Plan as it may consider necessary or appropriate for such purposes without thereby affecting the terms of the
Plan as in effect for any other purpose; provided, however, that no such supplements, amendments, restatements, or alternative
versions shall increase the share limitations contained in Section 4.1 of the Plan.

 

    8

     

    

 

Article 6

Options

 

6.1               
Grant of Options. Subject to the terms and provisions of the Plan, Options may be granted to Participants in such
number, and upon such terms and conditions, and at any time and from time to time as shall be determined by the Committee, in its
sole discretion, subject to the limitations set forth in Article 4 and the following terms and conditions:

 

(a)                
Award Agreement. Each Option grant shall be evidenced by an Award Agreement that shall specify the terms and conditions
of the Option, including the Exercise Price, the maximum duration of the Option, the number of Shares to which the Option pertains,
the conditions upon which an Option shall become vested and exercisable, and such other provisions as the Committee shall determine
which are not inconsistent with the terms of the Plan. The Award Agreement also shall specify whether the Option is intended to
be an Incentive Stock Option or a Non-Qualified Stock Option.

 

(b)               
Exercise Period. Unless a shorter period is otherwise provided by the Committee at the time of grant, each Option
will expire on the tenth (10th) anniversary date of its grant or on the fifth (5th) anniversary of its grant
date if the Participant is a Ten Percent Owner. Notwithstanding the foregoing, in the event that on the last business day of the
term of an Option (x) the exercise of which is prohibited by applicable law or (y) Shares may not be purchased or sold by certain
Employees or Directors of the Company due to a “black-out period” of a Company policy or a “lock-up” agreement
undertaken in connection with an issuance of securities by the Company, the Committee may provide that the term of the Option shall
be extended but not beyond a period of thirty (30) days following the end of the legal prohibition, black-out period or lock-up
agreement and provided further that no extension will be made if the grant price of such Option at the date the initial term would
otherwise expire is above the Fair Market Value.

 

(c)                
Exercise Price. Unless a greater Exercise Price is determined by the Committee, the Exercise Price for each Option
awarded under this Plan shall be equal to one hundred percent (100%) of the Fair Market Value of a Share on the date the Option
is granted. Notwithstanding the foregoing, the Committee may determine the Exercise Price for a substitute Award, provided such
Exercise Price does not violate applicable law (including, but not limited to, Section 409A of the Code).

 

(d)               
Vesting of Options. A grant of Options shall vest at such times and under such terms and conditions as determined
by the Committee including, without limitation, suspension of a Participant’s vesting during all or a portion of a Participant’s
leave of absence.

 

6.2               
Limitations on Incentive Stock Options. In addition to the general requirements of Article 6, the terms of
any Incentive Stock Option (“ISO”) granted pursuant to the Plan must comply with the provisions of this Section
6.2.

 

(a)                
ISO Eligibility. ISOs may be granted only to Employees of the Company or of any parent or subsidiary corporation
(as permitted under Sections 422 and 424 of the Code). No ISO Award may be made pursuant to this Plan after the tenth (10th) anniversary
of the Effective Date.

 

(b)               
ISO Individual Dollar Limitation. The aggregate Fair Market Value (determined as of the date the Option is granted)
of all Shares with respect to which Incentive Stock Options are first exercisable by a Participant in any calendar year may not
exceed one hundred thousand dollars ($100,000.00) or such other limitation as imposed by Section 422(d) of the Code. To the extent
that Incentive Stock Options are first exercisable by a Participant in excess of such limitation, the excess shall be considered
Non-Qualified Stock Options.

 

(c)                
ISO Expiration. An ISO will expire and may not be exercised to any extent by anyone after the first to occur of the
following events:

 

(i)                 
Ten (10) years from the date of grant, unless an earlier time is set in the Award Agreement;

 

(ii)               
Three (3) months after the date of the Participant’s Termination of Employment other than on account of Disability
or death. Whether a Participant continues to be an employee shall be determined in accordance with Treas. Reg. Section 1.421-1(h)(2);
and

 

(iii)             
One (1) year after the date of the Participant’s Termination of Employment on account of Disability or death. Upon
the Participant’s Disability or death, any ISOs exercisable at the Participant’s Disability or death may be exercised
by the Participant’s legal representative or representatives, by the person or persons entitled to do so pursuant to the
Participant’s last will and testament, or, if the Participant fails to make testamentary disposition of such ISO or dies
intestate, by the person or persons entitled to receive the ISO pursuant to the applicable laws of descent and distribution.

 

    9

     

    

 

Any ISO that remains exercisable pursuant to
a Participant’s agreement with the Company following Termination of Employment and is unexercised more than one (1) year
following Termination of Employment by reason of death or Disability or more than three (3) months following Termination of Employment
for any reason other than death or Disability will thereafter be deemed to be a Non-Qualified Stock Option.

 

(d)               
Ten Percent Owners. In the case of an ISO granted to a Ten Percent Owner, such ISO shall be granted at an exercise
price that is not less than one hundred and ten percent (110%) of Fair Market Value on the date of grant and, unless a shorter
period is otherwise provided by the Committee at the time of grant, each ISO will expire on the fifth (5th) anniversary
of its grant date.

 

(e)                
Notification of Disposition. If a Participant disposes of Shares acquired upon exercise of an ISO within two (2)
years from the date the Option is granted or within one (1) year after the issuance of such Shares to the Participant, the Participant
shall notify the Company of such disposition and provide information regarding the date of disposition, sale price, number of Shares
disposed of, and any other information relating thereto that the Company may reasonably request.

 

(f)                 
Right to Exercise. During a Participant’s lifetime, an Incentive Stock Option may be exercised only by the
Participant.

 

(g)               
Failure to Meet ISO Requirements. If an Option is intended to be an Incentive Stock Option, and if, for any reason,
such Option (or any portion thereof) shall not qualify as an Incentive Stock Option, then, to the extent of such nonqualification,
such Option (or portion thereof) shall be regarded as a Non-Qualified Stock Option appropriately granted under the Plan; provided
that such Option (or portion thereof) otherwise complies with the Plan’s requirements relating to Non-Qualified Stock
Options.

 

6.3               
Exercise of Options.

 

(a)                
Options granted under the Plan shall be exercisable at such times and be subject to such restrictions and conditions as
the Committee shall in each instance approve, which need not be the same for each grant or for each Participant. Exercises of Options
may be effected only on days and during the hours NASDAQ is open for regular trading. The Company may change or limit the times
or days Options may be exercised. If an Option expires on a day or at a time when exercises are not permitted, then the Options
may be exercised no later than the immediately preceding date and time that the Options were exercisable.

 

(b)               
An Option shall be exercised by providing notice to the designated agent selected by the Company (if no such agent has been
designated, then to the Company), in the manner and form determined by the Company, which notice shall be irrevocable, setting
forth the exact number of Shares with respect to which the Option is being exercised and including with such notice payment of
the Exercise Price, as applicable. When an Option has been transferred, the Company or its designated agent may require appropriate
documentation that the person or persons exercising the Option, if other than the Participant, has the right to exercise the Option.
No Option may be exercised with respect to a fraction of a Share.

 

6.4               
Termination of Employment. Unless otherwise provided by the Committee in the applicable Award Agreement, the following
limitations on the exercise of Options shall apply upon Termination of Employment:

 

(a)                
Termination by Death or Disability. In the event of the Participant’s Termination of Employment by reason of
death or Disability, all outstanding Options granted to such Participant which are vested and exercisable as of the effective date
of Termination of Employment by reason of death or Disability may be exercised, if at all, no more than one (1) year from such
date of Termination of Employment, unless the Options, by their terms, expire earlier. All unvested Options granted to such Participant
shall immediately become forfeited.

 

(b)               
Involuntary Termination Without Cause. If a Participant’s Termination of Employment is by involuntary termination
without Cause, all Options held by such Participant that are vested and exercisable at the time of the Participant’s Termination
of Employment may be exercised by the Participant at any time within a period of ninety (90) days from the date of such Termination
of Employment, but in no event beyond the expiration of the stated term of such Options. All Options held by the Participant which
are not vested on or before the effective date of Termination of Employment shall immediately be forfeited to the Company (and
the Shares subject to such forfeited Options shall once again become available for issuance under the Plan).

 

    10

     

    

 

(c)                
Voluntary Termination. If a Participant’s Termination of Employment is voluntary (other than a voluntary termination
described in Section 6.4(d)), all Options held by such Participant that are vested and exercisable at the time of the Participant’s
Termination of Employment may be exercised by the Participant at any time within a period of ninety (90) days from the date of
such Termination of Employment, but in no event beyond the expiration of the stated terms of such Options. All Options held by
the Participant which are not vested on or before the effective date of Termination of Employment shall immediately be forfeited
to the Company (and the Shares subject to such forfeited Options shall once again become available for issuance under the Plan).

 

(d)               
Termination for Cause. If the Participant’s Termination of Employment (i) is by the Company for Cause or (ii)
is a voluntary Termination (as provided in Subsection (c) above) after the occurrence of an event that would be grounds
for Termination of Employment for Cause, all outstanding Options held by the Participant shall immediately be forfeited to the
Company and no additional exercise period shall be allowed, regardless of the vested status of the Options (and the Shares subject
to such forfeited Options shall once again become available for issuance under the Plan).

 

(e)                
Other Terms and Conditions. A Participant holding an Option is not eligible to receive dividends or Dividend Equivalents.
Notwithstanding the foregoing, the Committee may, in its sole discretion, establish different, or waive, terms and conditions pertaining
to the effect of Termination of Employment on Options, whether or not the Options are outstanding, but no such modification shall
be materially adverse to the Participant.

 

6.5               
Payment. The Committee shall determine the methods by which payments by any Participant with respect to any Awards
granted under the Plan may be paid and the form of payment. Unless otherwise determined by the Committee, the Exercise Price shall
be paid in full at the time of exercise. No Shares shall be issued or transferred until full payment has been received or the next
business day thereafter, as determined by the Company. The Committee may, from time to time, determine or modify the method or
methods of exercising Options or the manner in which the Exercise Price is to be paid. Unless otherwise provided by the Committee
in full or in part, to the extent permitted by Applicable Law, payment may be made by any of the following:

 

(a)                
cash or certified or bank check;

 

(b)               
delivery of Shares owned by the Participant duly endorsed for transfer to the Company, with a Fair Market Value of such
Shares delivered on the date of delivery equal to the Exercise Price (or portion thereof) due for the number of Shares being acquired;

 

(c)                
if the Company has designated a stockbroker to act as the Company’s agent to process Option exercises, an Option may
be exercised by issuing an exercise notice together with instructions to such stockbroker irrevocably instructing the stockbroker:
(i) to immediately sell (which shall include an exercise notice that becomes effective upon execution of a sale order) a sufficient
portion of the Shares to be received from the Option exercise to pay the Exercise Price of the Options being exercised and the
required tax withholding, and (ii) to deliver on the settlement date the portion of the proceeds of the sale equal to the Exercise
Price and tax withholding to the Company. In the event the stockbroker sells any Shares on behalf of a Participant, the stockbroker
shall be acting solely as the agent of the Participant, and the Company disclaims any responsibility for the actions of the stockbroker
in making any such sales. However, if the Participant is an Insider, then the instruction to the stock broker to sell in the preceding
sentence is intended to comply with the requirements of Rule 10b5-1(c)(1)(i)(B) of the Exchange Act to the extent permitted by
law. No Shares shall be issued until the settlement date and until the proceeds (equal to the Exercise Price and tax withholding)
are paid to the Company;

 

(d)               
at any time, the Committee may, in addition to or in lieu of the foregoing, provide that an Option may be “stock settled,”
which shall mean upon exercise of an Option, the Company may fully satisfy its obligation under the Option by delivering that number
of shares of Stock found by taking the difference between (i) the Fair Market Value of the Stock on the exercise date, multiplied
by the number of Options being exercised and (ii) the total Exercise Price of the Options being exercised, and dividing such difference
by the Fair Market Value of the Stock on the exercise date; or

 

(e)                
any combination of the foregoing methods.

 

Notwithstanding any other provision of the Plan
to the contrary, no Participant who is a Director or an “executive officer” of the Company shall be permitted to pay
the Exercise Price of an Option in any method which would violate Section 13(h) of the Exchange Act.

 

    11

     

    

 

Article 7

 

Stock Appreciation Rights

 

7.1               
Grant of SARs. Any Participant selected by the Committee may be granted one or more SARs. SARs may be granted alone
or in tandem with Options. Each SAR shall be evidenced by an Award Agreement that shall specify the exercise price, the term of
the SAR, and such other provisions as the Committee shall determine. With respect to SARs granted in tandem with Options, the exercise
of either such Options or such SARs shall result in the simultaneous cancellation of the same number of tandem SARs or Options,
as the case may be.

 

7.2               
Exercise Price. The exercise price per Share covered by a SAR granted pursuant to the Plan shall be equal to or greater
than Fair Market Value on the date the SAR was granted.

 

7.3               
Term. The term of each SAR shall be determined by the Committee in its sole discretion, but in no event shall the
term exceed ten (10) years from the date of grant. Notwithstanding the foregoing, in the event that on the last business day of
the term of a SAR (x) the exercise of which is prohibited by applicable law or (y) Shares may not be purchased or sold by certain
Employees or Directors of the Company due to a “black-out period” of a Company policy or a “lock-up” agreement
undertaken in connection with an issuance of securities by the Company, the Committee may provide that the term of the SAR shall
be extended but not beyond a period of thirty (30) days following the end of the legal prohibition, black-out period or lock-up
agreement and provided further that no extension will be made if the grant price of such SAR at the date the initial term would
otherwise expire is above the Fair Market Value.

 

7.4               
Payment. SARs may be settled in the form of cash, shares of Stock or a combination of cash and shares of Stock, as
determined by the Committee.

 

7.5               
Other Provisions. Except as the Committee may deem inappropriate or inapplicable in the circumstances, SARs shall
be subject to terms and conditions substantially similar to those applicable to Non-Qualified Options as set forth in Article
6, including, but not limited to, the ineligibility to receive dividends or Dividend Equivalents.

 

Article 8

Restricted Stock Awards

 

8.1               
Grant of Restricted Stock. Subject to the terms and provisions of the Plan, the Committee, at any time and from time
to time, may grant shares of Restricted Stock to Eligible Persons in such amounts and upon such terms and conditions as the Committee
shall determine. In addition to any other terms and conditions imposed by the Committee, vesting of Restricted Stock may be conditioned
upon the achievement of Performance Goals.

 

8.2               
Restricted Stock Agreement. The Committee may require, as a condition to receiving a Restricted Stock Award, that
the Participant enter into a Restricted Stock Award Agreement, setting forth the terms and conditions of the Award. In lieu of
a Restricted Stock Award Agreement, the Committee may provide the terms and conditions of an Award in a notice to the Participant
of the Award, on the Stock certificate representing the Restricted Stock, in the resolution approving the Award, or in such other
manner as it deems appropriate. If certificates representing the Restricted Stock are registered in the name of the Participant,
any certificates so issued shall be printed with an appropriate legend referring to the terms, conditions, and restrictions applicable
to such Award as determined or authorized in the sole discretion of the Committee. Shares recorded in book-entry form shall be
recorded with a notation referring to the terms, conditions, and restrictions applicable to such Award as determined or authorized
in the sole discretion of the Committee. The Committee may require that the stock certificates or book-entry registrations evidencing
shares of Restricted Stock be held in custody by a designated escrow agent (which may but need not be the Company) until the restrictions
thereon shall have lapsed, and that the Participant deliver a stock power, endorsed in blank, relating to the Stock covered by
such Award.

 

8.3               
Restrictions. The Restricted Stock shall be subject to such vesting terms, including the achievement of Performance
Goals, as may be determined by the Committee. Unless otherwise provided by the Committee, to the extent Restricted Stock is subject
to any condition to vesting, if such condition or conditions are not satisfied by the time the period for achieving such condition
has expired, such Restricted Stock shall be forfeited. The Committee may impose such other conditions and/or restrictions on any
shares of Restricted Stock granted pursuant to the Plan as it may deem advisable including but not limited to a requirement that
Participants pay a stipulated purchase price for each share of Restricted Stock and/or restrictions under Applicable Law. The Committee
may also grant Restricted Stock without any terms or conditions in the form of vested Stock Awards.

 

    12

     

    

 

8.4               
Removal of Restrictions. Except as otherwise provided in this Article 8 or otherwise provided in the grant
thereof, Shares of Restricted Stock covered by each Restricted Stock grant made under the Plan shall become freely transferable
by the Participant after completion of all conditions to vesting, if any. However, the Committee, in its sole discretion, shall
have the right to waive all or part of the restrictions and conditions with regard to all or part of the shares held by any Participant
at any time.

 

8.5               
Voting Rights, Dividends and Other Distributions. Participants holding shares of Restricted Stock granted hereunder
may exercise full voting rights and, subject to the provisions of this Section 8.5, may receive all dividends and distributions
paid with respect to such Shares. If any such dividends or distributions are paid in Shares, the Shares shall automatically be
subject to the same restrictions and conditions as the Restricted Stock with respect to which they were paid. In addition, with
respect to a share of Restricted Stock, dividends shall only be paid out to the extent that the Share of Restricted Stock vests.
Any cash dividends and stock dividends with respect to the Restricted Stock shall be withheld by the Company for the Participant’s
account, and interest may be credited on the amount of the cash dividends withheld at a rate and subject to such terms as determined
by the Committee. The cash dividends or stock dividends so withheld by the Committee and attributable to any particular share of
Restricted Stock (and earnings thereon, if applicable) shall be distributed to the Participant in cash or, at the discretion of
the Committee, in shares of Stock having a Fair Market Value equal to the amount of such dividends, if applicable, upon the release
of restrictions on such share and, if such share is forfeited, the Participant shall have no right to such dividends.

 

8.6               
Termination of Employment Due to Death or Disability. In the event of the Participant’s Termination of Employment
by reason of death or Disability, unless otherwise determined by the Committee, all restrictions imposed on outstanding Shares
of Restricted Stock held by the Participant shall immediately lapse and the Restricted Stock shall immediately become fully vested
as of the date of Termination of Employment.

 

8.7               
Termination of Employment for Other Reasons. Unless otherwise provided by the Committee, in the event of the Participant’s
Termination of Employment for any reason other than those specifically set forth in Section 8.6 herein, subject to Section
10.2, all shares of Restricted Stock held by the Participant which are not vested as of the effective date of Termination of
Employment shall immediately be forfeited and returned to the Company.

 

8.8               
Section 83(b) Election. The Committee may provide in an Award Agreement that the Award of Restricted Stock is conditioned
upon the Participant making or refraining from making an election with respect to the Award under Section 83(b) of the Code. If
a Participant makes an election pursuant to Section 83(b) of the Code concerning a Restricted Stock Award, the Participant shall
be required to file a copy of such election with the Company within thirty (30) days following the date of grant.

 

8.9               
Restricted Stock Units. In lieu of or in addition to Restricted Stock, the Committee may grant Restricted Stock Units
under such terms and conditions as shall be determined by the Committee in accordance with Section 3.2. Restricted Stock
Units shall be subject to the same terms and conditions under this Plan as Restricted Stock except as otherwise provided in this
Plan or as otherwise provided by the Committee. Except as otherwise provided by the Committee, the award shall be settled and paid
out promptly upon vesting (to the extent permitted by Section 409A of the Code), and the Participant holding such Restricted Stock
Units shall receive, as determined by the Committee, Shares (or cash equal to the Fair Market Value of the number of Shares as
of the date the Award becomes payable) equal to the number of such Restricted Stock Units. Restricted Stock Units shall not be
transferable, shall have no voting rights, and, unless otherwise determined by the Committee, shall not receive dividends or Dividend
Equivalents (which in any event shall only be paid out to the extent that the Restricted Stock Units vest). Upon a Participant’s
Termination of Employment due to death or Disability, the Committee will determine whether there should be any acceleration of
vesting.

 

Article 9

Other Types of Awards

 

9.1               
Performance Share Awards. Any Participant selected by the Committee may be granted one or more Performance Share
awards which shall be denominated in a number of shares of Stock and which may be linked to any one or more of the Performance
Goals or other specific performance criteria determined appropriate by the Committee, in each case on a specified date or dates
or over any period or periods determined by the Committee. In making such determinations, the Committee shall consider (among such
other factors as it deems relevant in light of the specific type of award) the contributions, responsibilities and other compensation
of the particular Participant.

 

    13

     

    

 

9.2               
Performance Stock Units. Any Participant selected by the Committee may be granted one or more Performance Stock Unit
awards which shall be denominated in units of value including dollar value of shares of Stock and which may be linked to any one
or more of the Performance Goals or other specific performance criteria determined appropriate by the Committee, in each case on
a specified date or dates or over any period or periods determined by the Committee. In making such determinations, the Committee
shall consider (among such other factors as it deems relevant in light of the specific type of award) the contributions, responsibilities
and other compensation of the particular Participant.

 

9.3               
Dividend Equivalents. Any Participant selected by the Committee may be granted Dividend Equivalents based on the
dividends declared on the Shares that are subject to any Award, to be credited as of dividend payment dates, during the period
between the date the Award is granted and the date the Award is exercised, vests or expires, as determined by the Committee. Such
Dividend Equivalents shall be converted to cash or additional shares of Stock by such formula and at such time and subject to such
limitations as may be determined by the Committee, in a matter consistent with the rules of Section 409A of the Code; provided
that, to the extent Shares subject to an Award are subject to vesting conditions, any Dividend Equivalents relating to such Shares
shall be subject to the same vesting conditions.

 

9.4               
Deferred Stock. Any Participant selected by the Committee may be granted an award of Deferred Stock in the manner
determined from time to time by the Committee. The number of shares of Deferred Stock shall be determined by the Committee and
may be linked to the Performance Goals or other specific performance criteria determined to be appropriate by the Committee, in
each case on a specified date or dates or over any period or periods determined by the Committee. Stock underlying a Deferred Stock
Award will not be issued until the Deferred Stock Award has vested, pursuant to a vesting schedule or performance criteria set
by the Committee. Unless otherwise provided by the Committee, a Participant awarded Deferred Stock shall have no rights as a Company
stockholder with respect to such Deferred Stock until such time as the Deferred Stock Award has vested and the Stock underlying
the Deferred Stock Award has been issued.

 

9.5               
Other Stock-Based Awards. Any Participant selected by the Committee may be granted one or more Awards that provide
Participants with shares of Stock or the right to purchase shares of Stock or that have a value derived from the value of, or an
exercise or conversion privilege at a price related to, or that are otherwise payable in shares of Stock and which may be linked
to any one or more of the Performance Goals or other specific performance criteria determined appropriate by the Committee, in
each case on a specified date or dates or over any period or periods determined by the Committee. In making such determinations,
the Committee shall consider (among such other factors as it deems relevant in light of the specific type of Award) the contributions,
responsibilities and other compensation of the particular Participant.

 

9.6               
Performance Bonus Awards. Any Participant selected by the Committee may be granted one or more Awards in the form
of a cash bonus (a “Performance Bonus Award”) payable upon the attainment of Performance Goals that are established
by the Committee, in each case on a specified date or dates or over any period or periods determined by the Committee.

 

9.7               
Term. Except as otherwise provided herein, the term of any Award of Performance Shares, Performance Stock Units,
Dividend Equivalents, Deferred Stock, Other Stock-Based Award and Performance Bonus Award shall be set by the Committee in its
discretion.

 

9.8               
Exercise or Purchase Price. The Committee may establish the exercise or purchase price, if any, of any Award of Performance
Shares, Performance Stock Units, Deferred Stock, Other Stock-Based Award and Performance Bonus Award; provided, however, that such
price shall not be less than the Fair Market Value of a share of Stock on the date of grant, unless otherwise permitted by Applicable
Law.

 

9.9               
Exercise Upon Termination of Employment or Service. An Award of Performance Shares, Performance Stock Units, Deferred
Stock, Other Stock-Based Awards and Performance Bonus Awards shall only be exercisable or payable while the Participant is an Employee,
Consultant or Non-Employee Director, as applicable; provided, however, that the Committee in its sole and absolute discretion may
provide that an Award of Performance Shares, Performance Stock Units, Deferred Stock, Stock Appreciation Rights, Other Stock-Based
Award and Performance Bonus Award may be exercised or paid subsequent to a Termination of Employment without Cause. In the event
of the Termination of Employment of a Participant by the Company for Cause, all Awards under this Article 9 shall be forfeited
by the Participant to the Company.

 

9.10            
Form of Payment. Payments with respect to any Awards granted under this Article 9 shall be made in cash, in
Stock or a combination of both, as determined by the Committee.

 

9.11            
Award Agreement. All Awards under this Article 9 shall be subject to such additional terms and conditions
as determined by the Committee and shall be evidenced by a written Award Agreement.

 

    14

     

    

 

Article 10

Change in Control

 

10.1            
Vesting Upon Change in Control. For the avoidance of doubt, the Committee may not accelerate the vesting and exercisability
(as applicable) of any outstanding Awards, in whole or in part, solely upon the occurrence of a Change in Control except as provided
in this Section 10.1. In the event of a Change in Control after the date of the adoption of the Plan, then:

 

(a)                
to the extent an outstanding Award subject solely to time-based vesting is not assumed or replaced by a comparable Award
referencing shares of the capital stock of the successor corporation or its “parent corporation” (as defined in Section
424(e) of the Code) or “subsidiary corporation” (as defined in Section 424(f) of the Code) which is publicly traded
on a national stock exchange or quotation system, as determined by the Committee in its sole discretion, with appropriate adjustments
as to the number and kinds of shares and the exercise prices, if applicable, then any outstanding Award subject solely to time-based
vesting then held by Participants that is unexercisable, unvested or still subject to restrictions or forfeiture shall, in each
case as specified by the Committee in the applicable Award Agreement or otherwise, be deemed exercisable or otherwise vested, as
the case may be, as of immediately prior to such Change in Control;

 

(b)               
any stock-denominated performance-based Awards outstanding as of the date such Change in Control is determined to have occurred
shall be converted into, as applicable, time-based restricted stock of the successor corporation or its “parent corporation”
(as defined in Section 424(e) of the Code) or “subsidiary corporation” (as defined in Section 424(f) of the Code) or
time-based restricted stock units based on the capital stock of the successor corporation or its “parent corporation”
(as defined in Section 424(e) of the Code) or “subsidiary corporation” (as defined in Section 424(f) of the Code) and,
if, during the 12-month period following the date of such Change in Control, the Participant’s employment is terminated by
such successor (or an affiliate thereof) without Cause or by the Participant for Good Reason, such Awards, to the extent then outstanding,
shall fully vest. With respect to performance-based Awards that are outstanding as of the date of such Change in Control and are
not converted to a time-based Award, any deferral or other restriction shall lapse and such Awards shall be settled in cash as
promptly as is practicable (unless otherwise required by Section 409A of the Code and the applicable terms of the Awards). In either
case, unless otherwise determined by the Committee in an Award Agreement or otherwise, the value of the performance-based Awards
as of the date of the Change in Control shall be determined assuming target performance has been achieved, except that the value
shall be determined based on actual performance as of such date if (i) more than half of the performance period has elapsed as
of such date and (ii) actual performance is determinable as of such date; and

 

(c)                
Each outstanding Award that is assumed in connection with a Change in Control, or is otherwise to continue in effect subsequent
to the Change in Control, will be appropriately adjusted, immediately after the Change in Control, as to the number and class of
securities and other relevant terms in accordance with Section 4.3.

 

10.2            
Termination of Employment Upon Change in Control. Notwithstanding any other provision of the Plan to the contrary,
and except as may otherwise be provided in any applicable Award Agreement or other written agreement entered into between the Company
or Affiliate and a Participant, upon (i) a Participant’s involuntary Termination of Employment without Cause on or within
one (1) year following a Change in Control, or (ii) a Participant’s Termination of Employment for Good Reason (including
the Termination of Employment of the Participant if he or she is employed by an Affiliate at the time the Company sells or otherwise
divests itself of such Affiliate), all outstanding Awards shall immediately become fully vested and exercisable; provided that
Restricted Stock Units shall be settled in accordance with the terms of the grant without regard to the Change in Control unless
the Change in Control constitutes a “change in control event” within the meaning of Section 409A of the Code and such
Termination of Employment occurs within one (1) year following such Change in Control, in which case the Restricted Stock Units
shall be settled and paid out with such Termination of Employment.

 

10.3            
Cancellation and Termination of Awards. The Committee may, in connection with any merger, consolidation, share exchange
or other transaction entered into by the Company in good faith, determine that any outstanding Awards granted under the Plan, whether
or not vested, will be canceled and terminated and that in connection with such cancellation and termination the holder of such
Award may receive for each Share subject to such Award a cash payment (or the delivery of shares of stock, other securities or
a combination of cash, stock and securities equivalent to such cash payment) equal to the difference, if any, between the amount
determined by the Committee to be the Fair Market Value of the Stock and the purchase price per Share (if any) under the Award
multiplied by the number of Shares subject to such Award; provided that if such product is zero or less or to the extent that the
Award is not then exercisable, the Award will be canceled and terminated without payment therefor.

 

    15

     

    

 

Article 11

Amendment, Modification, and Termination

 

11.1            
Amendment, Modification, and Termination of Plan. At any time and from time to time, the Board may amend, modify,
alter, suspend, discontinue or terminate the Plan, in whole or in part, without stockholder approval; provided, however, that (a)
to the extent necessary and desirable to comply with any Applicable Law, regulation, or stock exchange rule, the Company shall
obtain stockholder approval of any Plan amendment in such a manner and to such a degree as required, and (b) stockholder approval
is required for any amendment to the Plan that (i) increases the number of shares available under the Plan (other than any adjustment
as provided by Section 4.3) or the number of shares available for issuance as ISOs, or (ii) permits the Committee to grant
Options with an Exercise Price that is below Fair Market Value on the date of grant (except as otherwise provided in Section
6.1), or (iii) permits the Committee to extend the exercise period for an Option beyond ten (10) years from the date of grant
(except as otherwise provided in Section 6.1), or (iv) results in a material increase in benefits or a change in eligibility
requirements, or (v) changes the granting corporation or (vi) changes the type of stock.

 

11.2            
Amendment of Awards. Subject to Section 4.3, at any time and from time to time, the Committee may amend the
terms of any one or more outstanding Awards, provided that the Award as amended is consistent with the terms of the Plan or if
necessary or advisable for the purpose of conforming the Plan or an Award Agreement to any present or future law relating to plans
of this or similar nature (including, without limitation, Section 409A), and to the administrative regulations and rulings promulgated
thereunder.

 

11.3            
Awards Previously Granted. No termination, amendment, or modification of the Plan or any Award shall adversely affect
in any material way any Award previously granted under the Plan, without the written consent of the Participant holding such Award;
provided, however, that any such modification made for the purpose of complying with Section 409A of the Code may be made by the
Company without the consent of any Participant.

 

11.4            
Repricing and Backdating Prohibited. Notwithstanding anything in this Plan to the contrary, except as provided under
Section 4.3 and Section 11.2, neither the Committee nor any other person may (i) amend the terms of outstanding Options
or SARs to reduce the exercise or grant price of such outstanding Options or SARs; (ii) cancel outstanding Options or SARs in exchange
for Options or SARs with an exercise or grant price that is less than the exercise price of the original Options or SARs; or (iii)
cancel outstanding Options or SARs with an exercise or grant price above the current Share price in exchange for cash or other
securities. In addition, the Committee may not make a grant of an Option or SAR with a grant date that is effective prior to the
date the Committee takes action to approve such Award.

 

Article 12

Withholding

 

12.1            
Tax Withholding. Unless otherwise provided by the Committee, the Company shall deduct or withhold any amount needed
to satisfy any foreign, federal, state, or local tax (including but not limited to the Participant’s employment tax obligations)
required by law to be withheld with respect to any taxable event arising or as a result of this Plan (“Withholding Taxes”).

 

12.2            
Share Withholding. Unless otherwise provided by the Committee, upon the exercise of Options, the lapse of restrictions
on Restricted Stock, the vesting of Restricted Stock Units the distribution of Performance Shares in the form of Stock, or any
other taxable event hereunder involving the transfer of Stock to a Participant, the Company shall withhold Stock equal in value,
using the Fair Market Value on the date determined by the Company to be used to value the Stock for tax purposes, to the Withholding
Taxes applicable to such transaction.

 

Unless otherwise determined by the Committee,
when the method of payment for the Exercise Price is from the sale by a stockbroker pursuant to Section 6.5(c), herein,
of the Stock acquired through the Option exercise, then the tax withholding shall be satisfied out of the proceeds. For administrative
purposes in determining the amount of taxes due, the sale price of such Stock shall be deemed to be the Fair Market Value of the
Stock.

 

If permitted by the Committee, prior to the
end of any Performance Period a Participant may elect to have a greater amount of Stock withheld from the distribution of Performance
Shares to pay withholding taxes; provided, however, the Committee may prohibit or limit any individual election or all such elections
at any time.

 

    16

     

    

 

Alternatively, or in combination with the foregoing,
the Committee may require Withholding Taxes to be paid in cash by the Participant or by the sale of a portion of the Stock being
distributed in connection with an Award, or by a combination thereof.

 

The withholding of taxes is intended to comply
with the requirements of Rule 10b5-1(c)(1)(i)(B) of the Exchange Act to the extent permitted by law.

 

Article 13

General Provisions Applicable to Awards

 

13.1            
Minimum Vesting Requirement. Notwithstanding any other provision of the Plan
to the contrary, Awards granted under the Plan (other than cash-based awards) shall vest no earlier than the first anniversary
of the date on which the Award is granted; provided, that the following Awards shall not be subject to the foregoing
minimum vesting requirement: any (i) substitute Awards granted in connection with awards that
are assumed, converted or substituted pursuant to a merger, acquisition or similar transaction entered into by the Company or any
of its Subsidiaries, (ii) Shares delivered in lieu of fully vested cash obligations, (iii) Awards to Non-Employee Directors that
vest on  the earlier of the one-year anniversary of the date of grant and the next annual meeting of stockholders which is
at least 50 weeks after the immediately preceding year’s annual meeting, and (iv) any additional Awards the Committee may
grant, up to a maximum of five percent (5%) of the available share reserve authorized for issuance under the Plan pursuant to Section
4.1 (subject to adjustment under Section 4.3); and, provided, further, that the foregoing restriction
does not apply to the Committee’s discretion to provide for accelerated exercisability or vesting of any Award, including
in cases of retirement, death, Disability or a Change in Control, in the terms of the Award Agreement or otherwise.

 

13.2            
Form of Payment. Subject to the provisions of this Plan, the Award Agreement and any Applicable Law, payments or
transfers to be made by the Company or any Affiliate on the grant, exercise, or settlement of any Award may be made in such form
as determined by the Committee including, without limitation, cash, Stock, other Awards, other property, or any combination thereof,
and may be made in a single payment or transfer, in installments, or any combination thereof, in each case determined by rules
adopted by the Committee.

 

13.3            
Treatment of Dividends and Dividend Equivalents on Unvested Awards. Notwithstanding any other provision of the Plan
to the contrary, with respect to any Award that provides for or includes a right to dividends or Dividend Equivalents, if dividends
are declared during the period that an equity Award is outstanding, such dividends (or Dividend Equivalents) shall either (a) not
be paid or credited with respect to such Award or (b) be accumulated but remain subject to vesting requirement(s) to the same extent
as the applicable Award and shall only be paid at the time or times such vesting requirement(s) are satisfied.

 

13.4            
Limits on Transfer.

 

(a)                
Except as otherwise provided in Section 13.4(b),

 

(i)                 
no Award may be sold, transferred, pledged, assigned, or otherwise alienated or hypothecated, other than by will or the
laws of descent and distribution or pursuant to a domestic relations order, unless and until such Award has been exercised, or
the Shares underlying such Award have been issues, and all restrictions applicable to such Shares have lapsed;

 

(ii)               
no Award or interest or right therein shall be liable for or otherwise subject to the debts, contracts or engagements of
the Participant or the Participant’s successors in interest or shall be subject to disposition by transfer, alienation, anticipation,
pledge, hypothecation, encumbrance, assignment or any other means whether such disposition be voluntary or involuntary or by operation
of law by judgment, levy, attachment, garnishment or any other legal or equitable proceedings (including bankruptcy) unless and
until such Award has been exercised, or the Shares underlying such Award have been issued, and all restrictions applicable to such
Shares have lapsed, and any attempted disposition of an Award prior to satisfaction of these conditions shall be null and void
and of no effect, except to the extent that such disposition is permitted by Section 13.4(a)(i); and

 

(iii)             
during a Participant’s lifetime, only the Participant or the Participant’s guardian or legal representative
may exercise an Award (or any portion thereof) granted to him or her under the Plan, unless it has been disposed of pursuant to
a domestic relations order. After a Participant’s death, any exercisable portion of an Award may, prior to the time when
such portion becomes unexercisable under the Plan or the applicable Award Agreement, be exercised by such Participant’s personal
representative or by any person empowered to do so under the deceased Participant’s will or under the then applicable laws
of descent and distribution.

 

    17

     

    

 

(b)               
Notwithstanding Section 13.4(a), the Committee, in its sole discretion, may determine to permit a Participant or
a Permitted Transferee of such Participant to transfer an Award other than an Incentive Stock Option (unless such Incentive Stock
Option is intended to become a Non-Qualified Stock Option) to any one or more Permitted Transferees of such Participant without
consideration, subject to the following terms and conditions: (i) an Award transferred to a Permitted Transferee shall not be assignable
or transferable by the Permitted Transferee other than (A) to another Permitted Transferee of the applicable Participant or (B)
by will or the laws of descent and distribution or, subject to the consent of the Committee, pursuant to a domestic relations order;
(ii) an Award transferred to a Permitted Transferee shall continue to be subject to all the terms and conditions of the Award as
applicable to the original Participant (other than the ability to further transfer the Award to any person other than another Permitted
Transferee of the applicable Participant); and (iii) the Participant (or transferring Permitted Transferee) and the receiving Permitted
Transferee shall execute any and all documents requested by the Committee, including, without limitation documents to (A) confirm
the status of the transferee as a Permitted Transferee, (B) satisfy any requirements for an exemption for the transfer under Applicable
Law and (C) evidence the transfer. In addition, and further notwithstanding Section 13.4(a), hereof, the Committee, in its
sole discretion, may determine to permit a Participant to transfer Incentive Stock Options to a trust that constitutes a Permitted
Transferee if, under Section 671 of the Code and other Applicable Law, the Participant is considered the sole beneficial owner
of the Incentive Stock Option while it is held in the trust.

 

13.5            
Beneficiaries. Notwithstanding Section 13.4, if provided in the applicable Award Agreement, a Participant
may, in the manner determined by the Committee, designate a beneficiary to exercise the rights of the Participant and to receive
any distribution with respect to any Award upon the Participant’s death. A beneficiary, legal guardian, legal representative,
or other person claiming any rights pursuant to the Plan is subject to all terms and conditions of the Plan and any Award Agreement
applicable to the Participant, except to the extent the Plan and Award Agreement otherwise provide, and to any additional restrictions
deemed necessary or appropriate by the Committee. If the Participant is married and resides in a community property state, a designation
of a person other than the Participant’s spouse as his or her beneficiary with respect to more than fifty percent (50%) of
the Participant’s interest in the Award shall not be effective without the prior written consent of the Participant’s
spouse. If no beneficiary has been designated or survives the Participant, payment shall be made to the person entitled thereto
pursuant to the Participant’s will or the laws of descent and distribution. Subject to the foregoing, a beneficiary designation
may be changed or revoked by a Participant at any time provided the change or revocation is filed with the Committee.

 

13.6            
Forfeiture Events/Representations. The Committee may specify in an Award Agreement at the time of the Award that
the Participant’s rights, payments and benefits with respect to an Award shall be subject to reduction, cancellation, forfeiture
or recoupment upon the occurrence of certain specified events, in addition to any otherwise applicable vesting or performance conditions
of an Award. Such events shall include, but shall not be limited to, termination of service for Cause, violation of material Company
policies, breach of noncompetition, confidentiality or other restrictive covenants that may apply to the Participant, or other
conduct by the Participant that is detrimental to the business or reputation of the Company. The Committee may also specify in
an Award Agreement that the Participant’s rights, payments and benefits with respect to an Award shall be conditioned upon
the Participant making a representation regarding compliance with noncompetition, confidentiality or other restrictive covenants
that may apply to the Participant and providing that the Participant’s rights, payments and benefits with respect to an Award
shall be subject to reduction, cancellation, forfeiture or recoupment on account of a breach of such representation. In addition
and without limitation of the foregoing, any amounts paid hereunder shall be subject to recoupment in accordance with The Dodd–Frank
Wall Street Reform and Consumer Protection Act and any implementing regulations thereunder, any “clawback” policy adopted
by the Company or as is otherwise required by applicable law or stock exchange listing condition.

 

Awards under the Plan shall be subject to the
Company’s clawback policy, as in effect from time to time. If there shall be no such clawback policy in effect, (1) awards
under the Plan and any Shares issued pursuant to Awards under the Plan (and any gains thereon) shall be subject to recovery or
“clawback” by the Company if and to the extent that the vesting of such Awards was determined or calculated based on
materially inaccurate financial statements or any other material inaccurate performance metric criteria; or (2) if the Company
or its Subsidiaries terminate a Participant’s service relationship due to the Participant’s gross negligence or willful
misconduct, or determine there are grounds for such a termination (whether or not such actions also constitute “cause”
under an Award Agreement), any Awards under the Plan, whether or not vested, as well as any shares of Stock issued pursuant to
Awards under this Plan (and any gains thereon) shall be subject to forfeiture, recovery and “clawback.” Notwithstanding
anything to the contrary contained herein, if a Participant has engaged in any detrimental activity (including noncompliance with
restrictive covenants), as determined by the Committee, the Committee may, in its sole discretion, provide for cancellation of
any or all of such Participant’s outstanding Awards and/or forfeiture by the Participant of any gain realized in respect
of Awards, and repayment of any such gain promptly to the Company.

 

    18

     

    

 

13.7            
No Fractional Shares. No fractional Shares shall be issued or delivered pursuant to the Plan or any Award. The Committee
shall determine whether cash, Awards, or other property shall be issued or paid in lieu of fractional Shares or whether such fractional
Shares or any rights thereto shall be forfeited or otherwise eliminated.

 

13.8            
Reservation of Stock. The Company shall at all times during the term of the Plan and any outstanding Awards granted
hereunder reserve or otherwise keep available such number of Shares of Stock as will be sufficient to satisfy the requirements
of the Plan (if then in effect) and the Awards and shall pay all fees and expenses necessarily incurred by the Company in connection
therewith.

 

13.9            
Reimbursement of Company for Unearned or Ill-gotten Gains. Unless otherwise specifically provided in an Award Agreement,
and to the extent permitted by Applicable Law, if the Company is required to prepare an accounting restatement due to the material
noncompliance of the Company with any financial reporting requirement under the securities laws, the Committee may, without obtaining
the approval or consent of the Company’s shareholders or of any Participant, require that any Participant who personally
engaged in one of more acts of fraud or misconduct that have caused or partially caused the need for such restatement or any current
or former chief executive officer, chief financial officer, or executive officer, regardless of their conduct, to reimburse the
Company in a manner consistent with Section 409A of the Code, if the Award constitutes “Non-Qualified Deferred Compensation,”
for all or any portion of any Awards granted or settled under this Plan (with each such case being a “Reimbursement”),
or the Committee may require the termination or rescission of, or the recapture associated with, any Award, in excess of the amount
the Participant would have received under the accounting restatement.

 

13.10        
Delay in Payment. To the extent required in order to avoid the imposition of any interest and/or additional tax under
Section 409A(a)(1)(B) of the Code, any amount that is considered deferred compensation under the Plan or Award Agreement and that
is required to be postponed pursuant to Section 409A of the Code, following the a Participant’s Termination of Employment
shall be delayed for six (6) months if a Participant is deemed to be a “specified employee” as defined in Section 409A(a)(2)(i)(B)
of the Code; provided that, if the Participant dies during the postponement period prior to the payment of the postponed amount,
the amounts withheld on account of Section 409A of the Code shall be paid to the executor or administrator of the decedent’s
estate within 60 days following the date of his death. A “Specified Employee” means any Participant who is a
“key employee” (as defined in Section 416(i) of the Code without regard to paragraph (5) thereof), as determined by
the Company in accordance with its uniform policy with respect to all arrangements subject to Section 409A of the Code, based upon
the twelve (12) month period ending on each December 31st (the “Identification Period”). All Participants who
are determined to be key employees under Section 416(i) of the Code (without regard to paragraph (5) thereof) during the identification
period shall be treated as Specified Employees for purposes of the Plan during the twelve (12) month period that begins on the
first day of the 4th month following the close of such identification period.

 

Article 14

Successors

 

All obligations of the Company under the Plan,
with respect to Awards granted hereunder, shall be binding on any successor to the Company, whether the existence of such successor
is the result of a direct or indirect purchase, merger, consolidation, or otherwise, of all or substantially all of the business
and/or assets of the Company.

 

Article 15

 

Miscellaneous Provisions

 

15.1            
Substitute Awards in Corporate Transactions. Nothing contained in the Plan shall be construed to limit the right
of the Committee to grant Awards under the Plan in connection with the acquisition, whether by purchase, merger, consolidation
or other corporate transaction, of the business or assets of any corporation or other entity. Without limiting the foregoing, the
Committee may grant Awards under the Plan to an employee or director of another corporation who becomes an Eligible Person by reason
of any such corporate transaction in substitution for awards previously granted by such corporation or entity to such person. The
terms and conditions of the substitute Awards may vary from the terms and conditions that would otherwise be required by the Plan
solely to the extent the Committee deems necessary for such purpose. Any shares of Stock subject to these substitute Awards shall
not be counted against the share reserve set forth in Article 4 of the Plan.

 

    19

     

    

 

15.2            
409A Compliance. It is intended that all Awards issued under the Plan be in a form and administered in a manner that
will comply with the requirements of Section 409A of the Code, or the requirements of an exception to Section 409A of the Code,
and the Award Agreement and this Plan will be construed and administered in a manner that is consistent with and gives effect to
such intent. The Committee is authorized to adopt rules or regulations deemed necessary or appropriate to qualify for an exception
from or to comply with the requirements of Section 409A of the Code. With respect to an Award that constitutes a deferral of compensation
subject to Section 409A of the Code: (a) if any amount is payable under such Award upon a termination of service, a termination
of service will be treated as having occurred only at such time the Participant has experienced a “separation from service”
as such term is defined for purposes of Section 409A of the Code; (b) if any amount is payable under such Award upon a disability,
a disability will be treated as having occurred only at such time the Participant has experienced a “disability” as
such term is defined for purposes of Section 409A of the Code; (c) if any amount is payable under such Award on account of the
occurrence of a Change in Control, a Change in Control will be treated as having occurred only at such time a “change in
the ownership or effective control of the corporation or in the ownership of a substantial portion of the assets of the corporation”
has occurred as such terms are defined for purposes of Section 409A of the Code, (d) if any amount becomes payable under such Award
on account of a Participant’s separation from service at such time as the Participant is a “specified employee”
within the meaning of Section 409A of the Code, then no payment shall be made, except as permitted under Section 409A of the Code,
prior to the first business day after the earlier of (i) the date that is six months after the date of the Participant’s
separation from service or (ii) the Participant’s death, (e) any right to receive any installment payments under this Plan
shall be treated as a right to receive a series of separate payments and, accordingly, each installment payment hereunder shall
at all times be considered a separate and distinct payment, and (f) no amendment to or payment under such Award will be made except
and only to the extent permitted under Section 409A of the Code.

 

Notwithstanding the foregoing, the tax treatment
of the benefits provided under the Plan or any Award Agreement is not warranted or guaranteed, and in no event shall the Company
be liable for all or any portion of any taxes, penalties, interest or other expenses that may be incurred by the Participant on
account of non-compliance with Section 409A of the Code.

 

15.3            
Section 16(b) of the Exchange Act. All elections and transactions under the Plan by persons subject to Section 16
of the Exchange Act involving shares of Stock are intended to comply with any applicable exemptive condition under Rule 16b-3.
The Committee may, in its sole discretion, establish and adopt written administrative guidelines, designed to facilitate compliance
with Section 16(b) of the Exchange Act, as it may deem necessary or proper for the administration and operation of the Plan and
the transaction of business thereunder.

 

15.4            
Unfunded Status of the Plan. The Plan is intended to constitute an “unfunded” plan for incentive compensation,
and the Plan is not intended to constitute a plan subject to the provisions of ERISA. With respect to any payments not yet made
to a Participant by the Company, nothing contained herein shall give any such Participant any rights that are greater than those
of a general creditor of the Company. In its sole discretion, the Committee may authorize the creation of trusts or other arrangements
to meet the obligations created under the Plan to deliver Stock or payments with respect to Options, Stock Appreciation Rights
and other Awards hereunder, provided, however, that the existence of such trusts or other arrangements is consistent with the unfunded
status of the Plan.

 

15.5            
Nonexclusivity of the Plan. Neither the adoption of the Plan by the Board nor the submission of the Plan to the stockholders
of the Company shall be construed as creating any limitations on the power of the Board to adopt such other incentive arrangements
as it may deem desirable, including without limitation, the granting of stock options and restricted stock other than under the
Plan, and such arrangements may be either applicable generally or only in specific cases.

 

15.6            
Investment Representations. The Company shall be under no obligation to issue any shares covered by any Award unless
the shares to be issued pursuant to Awards granted under the Plan have been effectively registered under the Securities Act of
1933, as amended, or the Participant shall have made such written representations to the Company (upon which the Company believes
it may reasonably rely) as the Company may deem necessary or appropriate for purposes of confirming that the issuance of such shares
will be exempt from the registration requirements of that Act and any applicable state securities laws and otherwise in compliance
with all applicable laws, rules and regulations, including but not limited to that the Participant is acquiring the shares for
his or her own account for the purpose of investment and not with a view to, or for sale in connection with, the distribution of
any such shares.

 

15.7            
Registration. If the Company shall deem it necessary or desirable to register under the Securities Act of 1933, as
amended or other applicable statutes any Shares of Stock issued or to be issued pursuant to Awards granted under the Plan, or to
qualify any such Shares of Stock for exemption from the Securities Act of 1933, as amended or other applicable statutes, then the
Company shall take such action at its own expense. The Company may require from each recipient of an Award, or each holder of Shares
of Stock acquired pursuant to the Plan, such information in writing for use in any registration statement, prospectus, preliminary
prospectus or offering circular as is reasonably necessary for that purpose and may require reasonable indemnity to the Company
and its officers and directors from that holder against all losses, claims, damage and liabilities arising from use of the information
so furnished and caused by any untrue statement of any material fact therein or caused by the omission to state a material fact
required to be stated therein or necessary to make the statements therein not misleading in the light of the circumstances under
which they were made. In addition, the Company may require of any such person that he or she agree that, without the prior written
consent of the Company or the managing underwriter in any public offering of Shares of Stock, he or she will not sell, make any
short sale of, loan, grant any option for the purchase of, pledge or otherwise encumber, or otherwise dispose of, any shares of
Stock during the 180 day period commencing on the effective date of the registration statement relating to the underwritten public
offering of securities. Without limiting the generality of the foregoing provisions of this Section 15.7, if in connection
with any underwritten public offering of securities of the Company the managing underwriter of such offering requires that the
Company’s directors and officers enter into a lock-up agreement containing provisions that are more restrictive than the
provisions set forth in the preceding sentence, then (a) each holder of shares of Stock acquired pursuant to the Plan (regardless
of whether such person has complied or complies with the provisions of clause (b) below) shall be bound by, and shall be deemed
to have agreed to, the same lock-up terms as those to which the Company’s directors and officers are required to adhere;
and (b) at the request of the Company or such managing underwriter, each such person shall execute and deliver a lock-up agreement
in form and substance equivalent to that which is required to be executed by the Company’s directors and officers.

 

    20

     

    

 

15.8            
Placement of Legends; Stop Orders; etc. Each share of Stock to be issued pursuant to Awards granted under the Plan
may bear a reference to the investment representation made in accordance with Section 15.6 in addition to any other applicable
restriction under the Plan, the terms of the Award and to the fact that no registration statement has been filed with the Securities
and Exchange Commission in respect to such shares of Stock. All shares of Stock or other securities delivered under the Plan shall
be subject to such stock transfer orders and other restrictions as the Committee may deem advisable under the rules, regulations,
and other requirements of any stock exchange upon which the Stock is then listed, and any applicable federal or state securities
law, and the Committee may cause a legend or legends to be put on any certificates or recorded in connection with book-entry accounts
representing the shares to make appropriate reference to such restrictions.

 

15.9            
Uncertificated Shares. To the extent that the Plan provides for issuance of certificates to reflect the transfer
of Shares, the transfer of such Shares may be effected on a noncertificated basis, to the extent not prohibited by Applicable Law.

 

15.10        
Limitation of Rights in Stock. A Participant shall not be deemed for any purpose to be a stockholder of the Company
with respect to any of the Shares of Stock subject to an Award, unless and until Shares shall have been issued therefor and delivered
to the Participant or his agent. Any Stock to be issued pursuant to Awards granted under the Plan shall be subject to all restrictions
upon the transfer thereof which may be now or hereafter imposed by the Certificate of Incorporation and the Bylaws of the Company.

 

15.11        
Employment Not Guaranteed. Nothing in the Plan shall interfere with or limit in any way the right of the Company
(or any Affiliate) to terminate any Participant’s Employment at any time, nor confer upon any Participant any right to continue
in the employ of the Company (or any Affiliate), subject to the terms of any separate employment or consulting agreement or provision
of law or corporate articles or by-laws to the contrary, at any time to terminate such employment or consulting agreement or to
increase or decrease, or otherwise adjust, the other terms and conditions of the recipient’s employment or other association
with the Company and its Affiliates.

 

15.12        
Other Compensation Arrangements. Nothing contained in this Plan shall prevent the Board from adopting other or additional
compensation arrangements, subject to shareholder approval if such approval is required; and such arrangements may be either generally
applicable or applicable only in specific cases.

 

15.13        
Gender and Number. Except where otherwise indicated by the context, any masculine term used herein also shall include
the feminine; the plural shall include the singular and the singular shall include the plural.

 

15.14        
Plan Headings. The headings in the Plan are for purposes of convenience only and are not intended to define or limit
the construction of the provisions thereof.

 

15.15        
Severability. In the event any provision of the Plan shall be held illegal or invalid for any reason, the illegality
or invalidity shall not affect the remaining parts of the Plan, and the Plan shall be construed and enforced as if the illegal
or invalid provision had not been included.

 

15.16        
Requirements of Law. The granting of Awards and the issuance of Shares under the Plan shall be subject to Applicable
Law and to such approvals by any governmental agencies or national securities exchanges as may be required.

 

15.17        
Errors. At any time the Company may correct any error made under the Plan without prejudice to the Company. Such
corrections may include, among other things, changing or revoking an issuance of an Award.

 

    21

     

    

 

15.18        
Elections and Notices. Notwithstanding anything to the contrary contained in this Plan, all elections and notices
of every kind shall be made on forms prepared by the Company or the general counsel, secretary or assistant secretary, or their
respective delegates or shall be made in such other manner as permitted or required by the Company or the general counsel, secretary
or assistant secretary, or their respective delegates, including but not limited to elections or notices through electronic means,
over the Internet or otherwise. An election shall be deemed made when received by the Company (or its designated agent, but only
in cases where the designated agent has been appointed for the purpose of receiving such election), which may waive any defects
in form. The Company may limit the time an election may be made in advance of any deadline.

 

Where any notice or filing required or permitted
to be given to the Company under the Plan, it shall be delivered to the principal office of the Company, directed to the attention
of the general counsel of the Company or his or her successor. Such notice shall be deemed given on the date of delivery.

 

Notice to the Participant shall be deemed given
when mailed (or sent by telecopy) to the Participant’s work or home address as shown on the records of the Company or, at
the option of the Company, to the Participant’s e-mail address as shown on the records of the Company.

 

It is the Participant’s responsibility
to ensure that the Participant’s addresses are kept up to date on the records of the Company. In the case of notices affecting
multiple Participants, the notices may be given by general distribution at the Participants’ work locations.

 

15.19        
Governing Law. To the extent not preempted by Federal law, the Plan, and all awards and agreements hereunder, and
any and all disputes in connection therewith, shall be governed by and construed in accordance with the substantive laws of the
State of Delaware, without regard to conflict or choice of law principles which might otherwise refer the construction, interpretation
or enforceability of this Plan to the substantive law of another jurisdiction.

 

15.20        
Venue. The Company and the Participant to whom an Award under this Plan is granted, for themselves and their successors
and assigns, irrevocably submit to the exclusive and sole jurisdiction and venue of the state or federal courts of Delaware with
respect to any and all disputes arising out of or relating to this Plan, the subject matter of this Plan or any awards under this
Plan, including but not limited to any disputes arising out of or relating to the interpretation and enforceability of any awards
or the terms and conditions of this Plan. To achieve certainty regarding the appropriate forum in which to prosecute and defend
actions arising out of or relating to this Plan, and to ensure consistency in application and interpretation of the Governing Law
to the Plan, the parties agree that (a) sole and exclusive appropriate venue for any such action shall be an appropriate federal
or state court in Delaware, and no other, (b) all claims with respect to any such action shall be heard and determined exclusively
in such Delaware court, and no other, (c) such Delaware court shall have sole and exclusive jurisdiction over the person of such
parties and over the subject matter of any dispute relating hereto and (d) that the parties waive any and all objections and defenses
to bringing any such action before such Delaware court, including but not limited to those relating to lack of personal jurisdiction,
improper venue or forum non conveniens.

 

15.21        
No Obligation to Notify. The Company shall have no duty or obligation to any holder of an Option to advise such holder
as to the time or manner of exercising such Option. Furthermore, the Company shall have no duty or obligation to warn or otherwise
advise such holder of a pending transaction or expiration of an Option or a possible period in which the Option may not be exercised.
The Company has no duty or obligation to minimize the tax consequences of an Option to the holder of such Option.

 

 

 

 

 

 

 

 

22

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00328-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00328-of-00352.parquet"}]]